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Structural variations (SVs), like single nucleotide polymorphisms (SNPs) and short
insertion-deletion polymorphisms (INDELs), are a ubiquitous feature of genomic sequences and
are major contributors to human genetic diversity and disease. Due to technical diﬃculties, i.e.
the high data-acquisition cost and/or low detection resolution of previous genome-scanning
technologies, this source of genetic variation has not been well studied until the completion of the
Human Genome Project and the emergence of next-generation sequencing (NGS) technologies.
ĉe assembly of the human genome and economical high-throughput sequencing technologies
enable the development of numerous new SV detection algorithms with unprecedented accuracy,
sensitivity and precision.
Although a number of SV detection programs have been developed for various SV types, such
as copy number variations, deletions, tandem duplications, inversions and translocations, some
types of SVs, e.g. copy number variations (CNVs) in capture sequencing data and mobile element
insertions (MEIs) have undergone limited study. ĉis is a result of the lack of suitable statistical
models and computational approaches, e.g. eﬃcient mapping method to handle multiple aligned
reads frommobile element (ME) sequences.
ĉe focus of my dissertation was to identify and characterize CNVs in capture sequencing data
andMEI from large-scale whole-genome sequencing data. ĉis was achieved by building
sophisticated statistical models and developing eﬃcient algorithms and analysis methods for
NGS data. In Chapter Ǌ, I present a novel algorithm that uses the read depth (RD) signal to
detect CNVs in deep-coverage exon capture sequencing data that are originally designed for SNPs
discovery. We were one of the early pioneers to tackle this problem. In Chapter ǋ, I present a fast,
convenient and memory-eﬃcient program, Tangram, that integrates read-pair (RP) and split-read
(SR) signals to detect and genotypeMEI events. Based on the results from both simulated and
experimental data, Tangram has superior sensitivity, speciėcity, breakpoint resolution and
genotyping accuracy, when compared to other recently publishedMEI detection methods.
Lastly, Chapter ǌ summarizes my work for SV detection in human genomes during my PhD study
and describes the future direction of genetic variant researches.
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1
Introduction
TļĹ ĹłŃŇŁŃŊň ĸĽŋĹŇňĽŉĽĹň in the human population can be explained bya diﬀerence of only ǈ.ǉƻ in the genomic sequence between any two individuals [ǉ, Ǌ].ĉus, identiėcation and characterization of these genetic variants is a crucial step in
understanding the link between the genomic information and phenotype. Genetic variations
between human genomes could range from a single nucleotide up to several million base pairs.
Despite this large size range, in the last ǉǍ years of the Ǌǈth century the study of these variants was
limited to large-scale events that can be observed under the microscope, such as
aneuploidies [ǋ–Ǎ], rearrangements [ǎ–ǐ], heteromorphisms [Ǒ–ǉǉ], chromosomal fragile
sites [ǉǊ], and single nucleotide polymorphisms (SNPs) that can be detected using traditional
ǉ
PCR-based DNA sequencing methods [ǉǋ]. Typically, variants under Ǎǈ bp are considered to be
short polymorphisms, including short insertion and deletion events. ĉose variants with sizes
ranging from Ǎǈ bp to millions of base pairs are typically termed as structural variations (SVs).
Due to the limitations of available technologies, these variants were not deeply studied until the
emergence and popularization of array-based comparative genome hybridization (array-CGH)
and next-generation sequencing (NGS) technologies. With these higher resolution technologies,
the whole-genome SV detection at the population scale became practicable. In the last ten years,
various types of SVs, including copy number variations (CNVs, such as deletions and
duplications) that alter the net amount of DNA and copy neutral variations (such as inversions
and translocations) that do not alter the net amount of DNA, have been discovered at a rapid rate.
By the end of June Ǌǈǉǋ, Ǌ,ǐǐǐ,ǍǊǎ CNVs and ǋ,ǋǐǈ inversions have been reported to the
Database of Genomic Variants (DGV) [ǉǌ]. Recent large international genome study projects,
e.g. the ǉǈǈǈ Genomes Projects [ǉǍ] and International Cancer Genome Consortium [ǉǎ], have
started to generate the map of almost all types of SVs at the single nucleotide resolution, which
further accelerates the SV research. ĉis map will set a solid stage for understanding the
relationship between genetic variants and phenotypic diversities and many common and rare
human diseases.
ǉ.ǉ SŉŇŊķŉŊŇĵŀ ŋĵŇĽĵŉĽŃł Ľł ļŊŁĵł ĸĽňĹĵňĹň ĵłĸ ńļĹłŃŉŏńĹň
Like SNPs, SVs are ubiquitous in the human genome and are a major source of genomic and
phenotypic diversities [ǉǏ]. Recent studies suggest an unexpected result that SVs actually aﬀect
more heritable DNA sequences than SNPs between individuals (ǈ.ǉƻ for SNPs and ǈ.Ǎƻ – ǉƻ
for SVs) [ǉǐ, ǉǑ]. Also the rate of novel SVs formed at a speciėc genomic location is relatively
high. A new locus-speciėc SV (de novo variant introduced at the same genomic location among
individuals) may occur in every Ǐ,ǈǈǈ newborns [Ǌǈ], which is at least ǉ,ǈǈǈ to ǉǈ,ǈǈǈ times
more frequent than locus-speciėc SNPs [Ǌǉ]. Although most SVs have a neutral phenotypic
eﬀect, mounting evidences show that some SVs play an important role in many phenotypic traits
Ǌ
Table 1.1.1: The phenotypic impact of copy number variation (CNV) in human genome.
The copy number change of genes may lead to various types of genetic disorders. CNVs have
been associated with many human diseases [30].
Aﬀected gene Copy number change Phenotype
GSĈǉ Deletion Halothane/epoxide sensitivity
GSTMǉ Deletion Toxin resistance, cancer susceptibility
CYPǊDǎ Ampliėcation Antidepressant sensitivity
CYPǊǉAǊ Ampliėcation Congenital andrenal hyperplasia
OPNǉLW, OPNǉMW Deletion X-linked color blindness
LPA Deletion Coronary heart disease risk
RHD Deletion Rhesus blood group sensitivity
CǌA/CǌB Deletion Systemic lupus erythematosus
DEFBǌ,ǉǈǋ Deletion Crohn’s disease, IBD
DEFBǌ,ǉǈǋ Ampliėcation Psoriasis
CCLǋLǉ Deletion HIV susceptibility
FCGRǋB Deletion SLE and glomerulonephritis
IRGM Deletion Crohn’s disease
GPRCǍB Upstream Deletion Obesity
Cǌ Ampliėcation Lupus
SMNǊ Ampliėcation Severity of spinal muscular atrophy
AZF region Deletion Spermatogenetic failure
UGTǊBǉǏ Deletion Graě-versus-host disease
NEGRǉ Upstream deletion Obesity
NBPFǊǋ Deletion Neuroblastoma
TSPANǐ Ampliėcation Type Ǌ diabetes
HLA Multiple CNVs Crohn’s disease, reheumatoid arthritis
LCEǋB, LCEǋC Deletion Psoriasis
CRIPAK Deletion Breast cancer
and genetic disorders, such as Mendelian disease [ǊǊ, Ǌǋ], sporadic chromosomal microdeletion
syndrome [Ǌǉ], autism [Ǌǌ, ǊǍ], schizophrenia [Ǌǎ] and diﬀerent types of cancers [ǊǏ–ǊǑ].
Table ǉ.ǉ.ǉ summarizes some human diseases that are correlated with SVs [ǋǈ].
In general, SVs can aﬀect the phenotype through two well-recognized mechanisms: dosage
eﬀect [ǋǉ, ǋǊ] and position eﬀect [ǋǋ]. Deletion and duplication (CNV) of genes and regulatory
elements may cause signiėcant dosage changes in the expression level (mRNAs) and the
translation level (proteins). If aﬀected genes are dosage-sensitive, these rearrangements can cause
genetic abnormalities. Results frommany studies carried out in model organisms like
mice [ǋǌ–ǋǎ] and transformed human cells [ǋǏ, ǋǐ] have demonstrated the close relationship
ǋ
between gene copy numbers and their expression levels. ĉe position eﬀect mechanism is
dominated by duplications and translocations. ĉese rearrangements can aﬀect the causative
gene even from a long distance (~ǉMbp). For example, a ~ǊMbp duplication has been found in
the regulatory region upstream of the SOXǑ gene to be associated with brachydactyly-anonychia
disease [ǋǑ]. Also, in the study of chronic myelogenous leukemia (CML), a recurrent
translocation between chromosome Ǒ and ǊǊ has been reported. ĉis rearrangement forms a
fusion gene between BCR and ABL genes that has been implicated in the development of this
type of cancer [ǌǈ]. A number of other mechanisms linking copy number changes with diseases
have also been proposed, including the coding sequence disruption [ǌǉ] and unmasking of
recessive mutations [ǌǊ].
ǉ.Ǌ TĹķļłŃŀŃĻĽĹň ĺŃŇ SV ĸĹŉĹķŉĽŃł
ǉ.Ǌ.ǉ CŏŉŃĻĹłĹŉĽķ ŁĹŉļŃĸň
As previously mentioned, the SV detection is generally limited by the development of
technologies. Back in ǉǑǊǈs, long before the establishment of modern molecular biology and
genomics, SVs could only be detected at a microscopic level (variants are so large that they can be
observed under the microscope). Mega-base-pair CNVs, inversions and chromosomal
rearrangements could be detected through cytogenetic methods such as chromosome banding
(Figure ǉ.Ǌ.ǉA), spectral karyotyping (SKY) (Figure ǉ.Ǌ.ǉB) and Ěuorescent in situ hybridization
(FISH) (Figure ǉ.Ǌ.ǉC, D, E, F, G and H) [ǉǏ]. ĉese large-scale genome abnormalities and
heteromorphisms are usually associated with severe genetic diseases like Down and Turner
syndrome [ǌǋ]. However, these types of SVs are rarely implicated in common complex diseases
and non-disease traits.
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Figure 1.2.1: Structure variation detection with cytogenetic technology. A. An inversion
event detected using the centromere (C)-banding method. B. A translocation event between
chromosome 7 and 13 detected using the spectral karyotyping (SKY) method. C. a translo-
cation between chromosome 3 and 7 detected using ﬂuorescence in situ hybridization (FISH)
carried out using metaphase chromosomes. D, E. copy number decrease and increase events
detected using the FISH method. In panel D, two copies of control probes (green) in chromo-
some 7 have been detected whereas the test probe (red) only presents on one of the homol-
ogous chromosome 7. In panel E, an ampliﬁcation signal is observed on chromosome 16 in
additional to the signal of two copies on chromosome 6. F. A micro inversion event of length
700kbp detected using a two-color FISH method. Reprinted from [44] with permission. G.
Two-color FISH has revealed a large genomic rearrangement (duplication). H. Copy number
diﬀerences can be detected with FISH. Reprinted from [14] with permission.
Ǎ
ǉ.Ǌ.Ǌ MĽķŇŃĵŇŇĵŏ
ĉe ėrst wave of systematic studies of SVs at the whole-genome level began in the late ǉǑǑǈs and
early Ǌǈǈǈs when the full assembly of the human genome [ǌǍ] and microarray technologies
(aCGH) [ǌǎ, ǌǏ] became available. Figure ǉ.Ǌ.Ǌ is a Ěow chart that demonstrates how a
microarray is used to detect SVs. ĉe sample and reference DNA are ėrst fragmented and then
labeled with diﬀerent Ěuorescent dyes, for example CyǍ and Cyǋ. Both sample and reference
DNA are then treated with COT-ǉ DNA that is primarily composed of repetitive sequences, to
block genomic regions with repeats. ĉese DNA sequences are then hybridized to arrays that are
covered with oligonucleotides (ǎǈ – ǉǈǈbp) derived from the reference genome. Finally, SVs
(deletions and duplications) can be detected by measuring the ratio of Ěuorescent signal between
the sample and reference DNA. To reduce the noise and false positive detection rate, array-CGH
usually includes an assay format called “dye-swap”. In this format, an extra hybridization is carried
out with sample and reference DNA swapping their Ěuorescent tag (say sample-CyǍ and
reference-Cyǋ for the ėrst hybridization and reference-CyǍ and sample-Cyǋ for the second
hybridization). ĉe ratio will be measured twice. ĉese two ratios are almost the reciprocal of
each other for real events. Any spurious calls can be excluded if only one ratio is oﬀ from the
neutral ratio (ǉ.ǈ), which might be caused by the random Ěuctuation of the Ěuorescent signal
instead of a real CNV event.
ĉe strength of this technology is its eﬀectiveness of both cost and time. In Ǌǈǈǈ, the
whole-genome shotgun sequencing (Sanger sequencing [ǌǐ]) was already being used in the
Human Genome Project. However, it is prohibitively expensive for the routine SV detection at
the population scale. Compared with the ėrst generation sequencing technology, microarrays are
vastly cheaper. Additionally, microarrays are very high-throughput: hundreds of thousands of
genomic regions can be probed for SV detections simultaneously on a single array, making it an
ideal method for large-scale projects. Microarrays can also be used to detect submicroscopic SV
events. In fact, a resolution on the order of tens kbp [ǉǏ] can be achieved. ĉis would be
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Figure 1.2.2: Array based, genome-wide methods for SV detection. Test and reference DNA
sequences are fragmented, labeled with diﬀerent ﬂuorescent tags and hybridized to arrays cov-
ered with oligonucleotide probes derived from the reference sequence. The copy number vari-
ants can be detected as those regions in which the ratio between sample and reference data
deviates signiﬁcantly from 1.0. To reduce noise, the sample and reference DNA sequences
have their ﬂuorescent tags swapped for an extra round of measurement. Reprinted from [17]
with permission.
practically impossible to observe using cytogenetic methods.
Although the development of microarrays was a signiėcant advance in SV detection
technology, it is not without its limitations. First of all, aCGH can be only used for detecting
CNVs (deletions and duplications), not copy neutral variations (inversions and translocations)
since it only measures the copy number diﬀerence between the sample and reference DNA.
Secondly, although microarray is a much improved genome-scanning technology, the Ěuorescent
signal is typically very noisy. ĉe signal can be aﬀected by many factors such as the base
composition, the proportion of repetitive sequences and the amount of “hybridizable” DNA in
the array element. ĉe Ěuorescent intensities can Ěuctuate by a factor of ǋǈ even if there are no
CNVs [ǌǑ]. Because of these reasons, microarray data normally require a sophisticated
computational process to decode. ĉis limits the sensitivity and breakpoint resolution to smaller
(under ǉ kbp) SVs of algorithms designed for microarray data. Last but not least, microarray
based methods are intentionally designed to avoid genomic regions embedded in repeat
Ǐ
sequences, making it insensitive to breakpoints located in repetitive elements, which compose ǎǎ
– ǎǑƻ of the human genome [Ǎǈ].
ǉ.Ǌ.ǋ NĹŎŉ-ĻĹłĹŇĵŉĽŃł ňĹŅŊĹłķĽłĻ
ĉe recent success in building up high-resolution SVmap within human populations is largely
aĨributable to the rapid development of the high throughput NGS technology. ĉeNGS
technology was ėrst introduced by Roche company with its ǌǍǌ sequencing machine in
ǊǈǈǍ [Ǎǉ]. Soon, many other companies like Illumina [ǍǊ], Applied Biosystem (ABI) [Ǎǋ] and
Complete Genomics [Ǎǌ] joined this market with their own NGS technologies. ĉe widespread
adoption of these sequencing technologies greatly facilitated the discovery of SVs. ĉe number of
reported SVs grew dramatically since the late Ǌǈǈǈs. Compared to the ėrst generation sequencing
technology, Sanger sequencing, NGS technology replaces the time-consuming bacterial cloning
with much more eﬃcient PCR techniques to amplify DNA samples (Figure ǉ.Ǌ.ǋ), which
signiėcantly reduces the sequencing cost (Table ǉ.Ǌ.ǉ [Ǎǌ, ǍǍ]). ĉe length of output reads (ǊǍ –
ǉǈǈ bp) fromNGSmachines is usually shorter than that of the Sanger sequencing (~ǉ kbp).
However, NGS is able to generate much more data per run: the latest Illumina HiSeq sequencing
machine can produce up to Ǌǈǈ Gb high quality reads per run in about eight days whereas the
most recent Sanger capillary machine introduced in ǉǑǑǑ can only produce ǉ.ǎ Mb data per run.
Also, most current NGS technologies apply the paired-end sequencing technique to increase the
eﬀective sequencing length. DNA samples are digested into long fragments with a length ranging
from several hundred base pairs to thousands base pairs, depending on the sequencing technology
and the ėnal read length. ĉen sequencing machines read the nucleotides from both sides of
these fragments and leave an unsequenced region in the middle. ĉe width of the distribution of
these fragments, or inserts, is usually very tight. ĉe fragment length of most sequencing reads is
within a very narrow region. So the mapping distance of a given pair of reads from this
technology can be easily estimated from this distribution if there are not any SVs occurring in the
ǐ
AB 
Figure 1.2.3: DNA ampliﬁcation methods used in next-generation sequencing technologies.
A. Emulsion PCR. This method is mainly used in 454 and Solid sequencing machines. DNA
fragments with adapters (gold and turquoise) are PCR ampliﬁed within a water-in-oil emul-
sion. B. Bridge PCR. Illumina invents this technique. One end of the DNA fragments for am-
pliﬁcation is ﬁrst ligated to adaptors that attached to a membrane. The other end of these
fragments is then ﬂanked with another adapter. The bridge-shape fragment will then be am-
pliﬁed iteratively as shown in the ﬁgure. Reprinted from [56] with permission.
Table 1.2.1: Approximate cost of generating reads with ƥ coverage of human genome by
using diﬀerent sequencing technologies [54, 55].
Technology Cost per ƥ
Sanger capillary Ʈǉ.ǌM
Roche ǌǍǌ ƮǑǋk
Illumina ƮǉǊǋ
ABI SOLiD Ʈǐk
Complete Genomics Ʈǉǉǈ
PacBio Ʈǎk
Ion Torrent Ʈǋk
Ǒ
unsequenced region. ĉis constraint provides valuable information to detect SVs with NGS data.
By utilizing the NGS technology, researchers can now identify a certain types of SVs in the
whole-genome and population scale, like deletions and duplications, at the single nucleotide
resolution with high accuracy. However, due to the limitations of the NGS technology, especially
the read length, and biological complexities of the human genome, some other types of SVs, e.g.
inversions (usually buried in repetitive regions) and mobile element insertions (MEIs, inserted
elements themselves are repetitive sequences), are hard to detect. ĉe detection of full-spectrum
SV types will require further advances in the sequencing technology (with read length at tens of
kbp) and the development of more sophisticated algorithms.
ǉ.ǋ AŀĻŃŇĽŉļŁň ĺŃŇ SV ĸĹŉĹķŉĽŃłŌĽŉļNGS ĸĵŉĵ
NGS data opened many possibilities for bioinformaticians to develop diﬀerent types of
computational methods to comprehensively identify and characterize SVs in human genomes. To
handle the huge amount of data generated fromNGSmachines, many eﬃcient algorithms that
take advantage of diﬀerent aspects of sequencing data have been proposed. Most of these
approaches are based on the resequencing strategy— sequencing reads have to be ėrst mapped to
the reference genome with aligners, such asMOSAIK [ǍǏ], BWA [Ǎǐ] and BFAST [ǍǑ], and then
the SVs can be detected as the diﬀerences between alignment reads and the human genome
reference, the major achievement of the Human Genome Project. Due to the limitations of
current sequencing technologies (short read length and fragment length) and biological features
of the human genome (full of repetitive elements), many reads cannot be aligned uniquely to the
reference genome. Reads that can be mapped to multiple positions are usually assigned only to a
random location by most of sequencing alignment programs with a lowmapping quality (ǈ, in
most cases) that is dominantly aﬀected by the number of locations a read can be aligned in
addition to some other factors such as the number of mismatches in the alignment and base
qualities of the sequencing read and excluded from the analysis by most of SV detection programs
for the sake of lower false discovery rate (FDR). However, in order to detect some complicated
ǉǈ
types of SV, such as MEI, these ambiguous reads have to be taken into account with special
handling at both the primary aligning level and SV detection level— the aligner must provide the
extra information about these reads, such as the type of repetitive elements where these reads are
sampled, for the downstream analysis.
ĉis section will review three most frequently applied algorithms in current available SV
detectors for NGS data: read depth (RD), read pair (RP) and split read (SR).
ǉ.ǋ.ǉ RĹĵĸ ĸĹńŉļ ĵŀĻŃŇĽŉļŁ
ĉe depth of coverage is one of the well-known statistics to describe the quality of NGS
alignment data— usually the higher the coverage the beĨer the data. In most cases, the depth of
coverage refers to the base coverage: the number of reads that contain a certain nucleotide in the
reference sequence: c = NLG , where c is the base coverage,N is the number of sequencing reads, L
is the average length of reads andG is the length of the reference sequence. ĉere is another
expression of the depth of coverage that is oěen used in the CNV detection: read depth, the
number of alignments (DNA fragments) that fall into a given size of window at a particular
genome location. By analyzing the read depth (RD) signal with NGS alignment data, CNVs can
be detected with the similar computational method that is applied on microarray data. Instead of
measuring the diﬀerence of the Ěuorescent intensity between the sample and reference DNA, the
RDmethod measures the diﬀerence between the observed read depth and the expected or
control read depth. For example, the observed read depth at a given genome region should be
about half of the expected or control read depth if the genomic region harbors a heterozygous
deletion or about zero if the genomic region harbors a homozygous deletion (Figure ǉ.ǋ.ǉ). In
this method, the whole genome region is ėrst segmented into numerous non-overlap windows
with ėxed size around Ǎǈ bp – ǉǈǈ bp (depending on the quality of the data) and then the
algorithm will count howmany alignments (the start of each alignment) are within each of these
windows. Each of these counts is the observed read depth. To detect CNVs, it is also necessary to
estimate the number of read counts in the same window if there is no CNV at all (null
ǉǉ
hypothesis). One eﬃcient way of estimating expected read counts is to generate the same amount
of simulated reads with the same read length as the real sequencing data from the reference
genome with a practical error model (sequencing error) similar to the sequencing technology
used for generating the real data. Many toolboxes, such as WgSim [ǎǈ] andMASON [ǎǉ], can be
used for this task. ĉe simulated reads will be aligned with the same aligner and the same
parameters as the real sequencing data and the count of simulated alignments at the
corresponding window will be served as the expected read depth. In cancer sequencing data,
there is usually no need to generate simulated data since the number of alignments from the
normal tissue in the same patient can be served as the control read depth. If we assume that
sequencing reads are sampled uniformly from the genome, the number of observed read depth at
a given window should follow the Poisson distribution with the median of RDexpected and the
standard deviation of
p
RDexpected. ĉe candidate CNV events then can be detected with a
pre-deėned p-value threshold. In practice, detectors using the RD signal usually call a CNV event
only if at least two or three consecutive windows all have the signiėcant diﬀerence between the
observed read depth and the expected read depth for speciėcity consideration.
ĉe advantage of this algorithm is that it is computationally lightweight since only the
alignment position of each read is used for calculation. Aěer calculating the read count for each
window, the rest of computational work can be easily performed even with a personal computer.
Moreover, the RD algorithm can be applied to both whole-genome sequencing data and the
capture sequencing data where sequencing reads are only from selected genomics regions, such as
exons. ĉemajor problem of CNV detection in capture sequencing is that breakpoints may not
be included in sequencing regions, which is a requirement for RP and SR algorithms. Since the
RD algorithm only measures the read depth change breakpoint positions being outside the
sequencing region does not aﬀect the detection of CNVs.
Like microarray technology, the major limitation of the RD algorithm is the relatively low
breakpoint resolution (approximately several hundred base pairs, Figure ǉ.ǋ.Ǌ) and sensitivity to
smaller events. Although NGS is technologically beĨer than aCGH, the RD signal is still
ǉǊ
Figure 1.3.1: Detection of a homozygous deletion event with split read (red read in the mid-
dle) and read depth (bottom panel) signal. Reprinted from [62] with permission.
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Figure 1.3.2: Breakpoint resolution (blue for start position and red for end position) of dele-
tion events detected by the read depth method with WGS data in the 1000 Genomes Project
Pilot studies [63].
sometimes too noisy to precisely locate CNVs and sensitively detect those small events.
Moreover, the RD algorithm is totally blind to copy neutral variations like inversions and
balanced translocations since it only measures read count changes.
ǉ.ǋ.Ǌ RĹĵĸ ńĵĽŇ ĵŀĻŃŇĽŉļŁ
ĉe RP algorithm takes advantage of a special feature of the NGS technology, paired-end
mapping. In the protocol of current available sequencing technologies, the input sample DNA is
usually sheared into small fragments, ranging from several hundred to several thousand base pairs.
ĉe sequencing machine will read nucleotides from both ends of each fragment and leave an
unsequenced region in the middle. ĉe length of fragments from the same batch of sequencing
ǉǌ
jobs should be within a very narrow range. If the unsequenced region of the fragment does not
harbor any SVs then the mapping distance between the two mates of a read pair should be slightly
deviated from the expected fragment length. ĉese pairs are called concordant pairs. If there is an
SV between the two mates then the mapping distance of them should be much diﬀerent from the
expected fragment. For example, if a read pair span a deletion breakpoint, the mapping length of
this read pair should be signiėcantly larger than its fragment length due to the absence of the
deleted region in the sample DNA and the existence of it in the reference genome. ĉese pairs are
called discordant pairs (Figure ǉ.ǋ.ǋ leě panel). So the ėrst step in the RP algorithm is to calculate
the fragment length distribution from those read pairs with high mapping qualities (both mates
are uniquely aligned with fewmismatches, Figure ǉ.ǋ.ǋ right panel). SV candidates then can be
identiėed as those read pairs on both edges of the fragment length distribution with a pre-deėned
p-value cutoﬀ. ĉese read pairs will then be clustered with a particular clustering algorithm to
increase the detection speciėcity. Most SV detectors equipped with the RP algorithm required a
minimum number of candidate fragments in a cluster to make an event call to reduce the
possibility of false detections. Since the exact length of DNA fragments input into the sequencing
machine is unknown, the breakpoint position and the length of the detected event can be only
estimated approximately from the mapping positions of alignment reads in the cluster and the
fragment length distribution. For example, a cluster with two discordant reads identiėes a
deletion event. ĉe read length of these two pairs is ėxed: Ǎǈ bp. ĉemapping start and end
positions of the ėrst mates in the ėrst pair are: ǉǈǈǈ bp and ǉǈǌǑ bp. ĉemapping start and end
positions of the second mate are: Ǌǈǈǈ bp and ǊǈǌǑ bp. ĉe corresponding mapping start and
end position of the twomates in the second pair are: ǉǉǈǈ bp, ǉǉǌǑ bp, ǊǈǍǈ bp and ǊǈǑǑ bp. ĉe
median fragment length of this sequencing library is Ǎǈǈ bp. It represents the expected fragment
length without any SV events. Based on the information given above, we can estimate the
breakpoint position of this deletion event to be at ǉǉǌǑ bp, the rightmost position of the mapping
end position of the ėrst mate in these two pairs, and the event length to be ǍǊǍbp, the average
diﬀerence between mapping distances of these two pairs and the median fragment length,
ǉǍ
Figure 1.3.3: Illustrations of concordant, discordant pairs (left panel) and fragment length
distribution (right panel). The discordant pairs can be identiﬁed as those alignments whose
mapping distance between two mates does not agree with the fragment length distribution or
mapping orientation does not agree with the expected read orientation. The left panel demon-
strates an instance of using discordant pair to detect a deletion event. Reprinted from [62]
with permission.
(ǉǈǍǈbp – Ǎǈǈbp + ǉǈǈǈbp – Ǎǈǈbp) / Ǌ. Besides the fragment length, the orientation of a read
pair can also provide useful information for SVs detection. For a given sequencing technology,
the orientation of two mates in a read pair should follow a predictable paĨern if they are sampled
from a genomic region without any SVs. For example, the orientation paĨern of read pairs from
Illumina sequencing machines is that the mate with smaller genomic position should be on the
positive strand and the mate with larger genomic position should be on the minus strand. If one
mate of a read pair hits a inversion then its orientation will be diﬀerent from the expected
orientation. Inversion events can be identiėed through grouping these mis-oriented read pairs.
ĉe advantage of the RP algorithm is that it provides much higher breakpoint resolution. ĉe
uncertainty of reported events by the RP algorithm is usually around Ǎǈ – ǉǈǈ bp (Figure ǉ.ǋ.ǌ),
depending on the coverage and the shape of the fragment length distribution. Also, the RP signal
is generally very strong and clear. It usually requires a few RP supporting fragments to identify a
SV event. So the RPmethod can be applied to low coverage data (~Ʃ). Moreover, the RP
algorithm cannot only identify CNV events such as deletions and duplications but also can detect
copy neutral variation like inversions and translocations. Almost all types of SVs have their
corresponding RP signatures. For example, the RP signature for deletions is that the mapping
length of a read pair is larger than the expected fragment length; the RP signature for insertions is
ǉǎ
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Figure 1.3.4: Breakpoint resolution (blue for start position and red for end position) of dele-
tion events detected by the read pair method with WGS data in the 1000 Genomes Project
Pilot studies [63].
that the mapping length of a read pair is smaller than the expected fragment length; the RP
signature for inversions is that the mapping orientation of a read pair is discordant with the
expected orientation (the mapping length might be discordant too); the RP signature for
translocations is that two mates of a read pair will be aligned to two diﬀerent chromosomes.
ĉemajor limitation of this approach is that the detection sensitivity to SV events highly
depends on the quality of the fragment length distribution. If the fragment length distribution of
sequencing data is in regular shape (bell-shaped) and tight (Figure ǉ.ǋ.ǍA), the RP algorithm can
achieve high detection eﬃciency. However, if the fragment length distribution is wide and in
irregular shape(Figure ǉ.ǋ.ǍB), it might limit the sensitivity of the RP algorithm. Also, although
the RP algorithm can provide much beĨer breakpoint resolution than the RD algorithm, it still
ǉǏ
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Figure 1.3.5: Two diﬀerent fragment length distributions from two diﬀerent sequencing li-
braries of a 1000GP sample (WGS), NA12878.
can only provide the approximate position of a reported SV instead of the exact breakpoint
location.
ǉ.ǋ.ǋ SńŀĽŉ ŇĹĵĸ ĵŀĻŃŇĽŉļŁ
ĉe SR algorithm is the latest player for SV discovery. ĉe ėrst SV detection program based on
the SR algorithm, Pindel [ǎǌ], is not published until ǊǈǈǑ. Before that, few detectors take those
unaligned reads and soě clipped reads (only part of these reads can be aligned to the reference
genome) into account for SV detection since they are hard to handle. ĉese reads are usually
sampled from genome regions that cross SV breakpoints. ĉe basic idea of the SR algorithm is to
split these unaligned and soě clipped reads into several partial reads so that they can be aligned
separately to diﬀerent genome positions, before breakpoints, within SVs and/or aěer breakpoints
(Figure ǉ.ǋ.ǉ). For example, one mate of a read pair with ǉǈǈ bp length crosses a deletion (Ǎǈǈ
bp) breakpoint in the middle. ĉis mate is actually a fusion read with the ėrst Ǎǈ bp before the
deletion region and the second Ǎǈ bp aěer the deletion region. ĉis read usually cannot be
aligned back to the reference genome or it will be aligned with Ǎǈ bp soě clipped (either the ėrst
ǉǐ
or the second Ǎǈ bp). With the SR algorithm, the ėrst Ǎǈ bp partial alignment can be found by
searching a local region, about Ǌ times of the median fragment length, around the other anchor
mate (usually required to be aligned uniquely to the genome). ĉe second Ǎǈ bp partial
alignment can be then found in a region aěer the mapping end position of the ėrst partial
alignment. For running time consideration, the size of the search region for the second partial
alignment is usually limited to several kbp to ǉ mbp since large-size SVs are generally very rare.
Aěer both partial alignments are found the position, the length and type of the detected variation
can be determined. To avoid high FDR, most SV detectors based on the SR algorithm require at
least two SR alignments for a given call.
ĉe advantage of the SR algorithm is that it can locate SV at the single nucleotide resolution
(Figure ǉ.ǋ.ǎ), which is a huge improvement from RD and RP algorithms. ĉemapping position
and orientation of partial alignments can provide the precise information about the location,
length and type of reported SVs. Like the RP algorithm, the SRmethod can detect almost all
types of simple SVs as well as some complex events.
Although powerful, the SR algorithm requires an additional mapping eﬀort aěer the primary
alignment. Depending on the size of the search region for the second partial alignment, the length
of sequencing reads and the base coverage of the alignment, the split mapping step may become
time-consuming. Moreover, a long read length (>Ǎǈ bp) is usually required for reliable split
mapping results.
ĉree algorithms utilize reads sampled from three diﬀerent regions associated with SVs:
candidates for the RD algorithm are those reads inside SV events; candidates for the RP algorithm
are those reads whose two mates span SV breakpoints; and candidates for the SR algorithm are
those reads that one mate is uniquely aligned to the normal reference region and the other mate
hits the breakpoint of a SV event. ĉese three sources of signal for SV detection are generally
independent of each other. Several recently published SV detectors, such as DELLY [ǎǍ] and
Tangram (described in Chapter ǋ), utilize two or more algorithms together for higher detection
eﬃciency and speciėcity. As the read length becomes longer, we could anticipate that toolboxes
ǉǑ
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Figure 1.3.6: Breakpoint resolution (blue for start position and red for end position) of dele-
tion events detected by the split read method with WGS data in the 1000 Genomes Project
Pilot studies [63].
Ǌǈ
that integrate de novo or local assembly algorithms will soon become available in the near future.
Ǌǉ
If youwould be a real seeker aĜer truth, it is necessary that at
least once in your life you doubt, as far as possible, all things.
Rene Descartes
2
CNVdetection from exon capture sequencing data
DNA ķĵńŉŊŇĹ ŉĹķļłŃŀŃĻĽĹň combined with high-throughput sequencingnow enable cost-eﬀective, deep-coverage, targeted sequencing of complete exomes.ĉis is well suited for SNP discovery and genotyping. However, there has been liĨle
aĨention devoted to Copy Number Variation (CNV) detection from exome capture datasets
despite the potentially high impact of CNVs in exonic regions on protein function.
As members of the ǉǈǈǈ Genomes Project analysis eﬀort, we investigated ǎǑǏ samples in
which Ǒǋǉ genes were targeted and sampled with ǌǍǌ or Illumina paired-end sequencing. We
developed a rigorous Bayesian method to detect CNVs in the genes, based on read depth within
target regions. Despite substantial variability in read coverage across samples and targeted exons,
ǊǊ
we were able to identify ǉǈǏ heterozygous deletions in the dataset. ĉe experimentally
determined false discovery rate (FDR) of the cleanest dataset from theWellcome Trust Sanger
Institute is ǉǊ.Ǎƻ. We were able to substantially improve the FDR in a subset of gene deletion
candidates that were adjacent to another gene deletion call (ǉǏ calls with ǈƻ FDR). From the
simulation experiment and our calculation, the estimated sensitivity of our call-set was ǌǍƻ.
ĉis study demonstrates that exonic sequencing datasets, collected both in population based
and medical sequencing projects, will be a useful substrate for detecting genic CNV events,
particularly deletions. Based on the number of events we found and the sensitivity of the
methods in the present dataset, we estimate on average ǉǎ genic heterozygous deletions per
individual genome. Our power analysis informs ongoing and future projects about sequencing
depth and uniformity of read coverage required for eﬃcient detection.
Ǌ.ǉ IłŉŇŃĸŊķŉĽŃł
Copy Number Variations (CNVs) i.e. deletions and ampliėcations, are an essential part of normal
human variability [ǎǎ]. Speciėc CNV events have also been associated with various human
diseases [ǎǏ], including cancer [ǎǐ] autism [ǎǑ, Ǐǈ] and schizophrenia [Ǐǉ]. Historically, large
CNV events can be observed using FISH [ǉǌ] but systematic, genome-wide discovery of CNVs
started with microarray-based methods [ǏǊ–Ǐǌ] which can detect events down to tens of kbp. As
with all hybridization based approaches, these methods are blind in repetitive and low complexity
regions of the genome where probes cannot be designed. High throughput sequencing with
next-generation technologies have enabled CNV detection at higher resolution (i.e. down to
smaller event size), in whole-genome shotgun datasets [ǎǋ, ǏǍ, Ǐǎ]. However, despite decreasing
costs, deep-coverage ( ƦƩ) whole-genome data is still prohibitively expensive for routine
sequencing of hundreds of samples, and in low-coverage (Ǌ-ƪ base coverage) datasets detection
sensitivity and resolution is limited to long genomic events [ǎǎ].
Targeted DNA capture technologies combined with high-throughput sequencing now provide
a reasonable balance between coverage and sequencing cost in a substantial portion of the
Ǌǋ
genome, and full-exome sequencing projects are presently collecting ƦƩ average sequence
coverage in thousands of samples. CNV events in exonic regions are important because the
deletions of one or both copies, or ampliėcations aﬀecting exons, are likely to incur phenotypic
consequences.
Current algorithms for detecting CNVs in whole-genome shotgun sequencing data use one of
four types of signal as evidence for an event: (ǉ) aberrantly mapped mate-pair reads (RP or read
pair methods); (Ǌ) split-read mapping positions (SR); (ǋ) de novo assembly (AS); and (ǌ) a
signiėcant decrease or increase of mapped read depth (RDmethods). Unfortunately, these
methods are not generally applicable for CNV detection in capture sequence data without
substantial modiėcations. SR, RP, and AS based methods are sensitive only to CNVs in which
mapped reads or fragments span the event breakpoint(s). In the case of exon capture data, this
restricts detection to CNV events where at least one breakpoint falls in a targeted exon. RD based
methods suﬀer from large Ěuctuations of sequence coverage stemming from variability in
probe-speciėc hybridization aﬃnities across diﬀerent capture targets (in this case: exons) and
sets of such targets (in our case: genes), and from the over-dispersion of the read coverage
distribution in the same target across diﬀerent samples. Presumably because of the technical
challenges, and despite the importance of deletion or ampliėcation events within exons, there are
currently no reported CNV detection algorithms for targeted DNA capture based
exon-sequencing data (with the exception of methods for tumor-normal datasets [ǏǏ] where the
read depth measured in the normal sample can be used for normalization, which is not available
in the case of population sequencing).
In this study, we set out to develop a CNV detection algorithm for capture sequencing data.
ĉis algorithm is based on RDmeasurement, and detects samples with non-normal copy number
in the capture target regions. As participants of the ǉǈǈǈ Genomes Project, we took part in the
data analysis of the “Exon Sequencing Pilot” dataset [ǉǍ], where ǉǊ,ǌǏǍ exons from over Ǒǈǈ
genes (representing about ǉǈƻ of the whole exome) were targeted and sequenced with a variety
of DNA capture sequencing technologies.
Ǌǌ
Ǌ.Ǌ RĹňŊŀŉň
Ǌ.Ǌ.ǉ BŇĽĹĺ ĵŀĻŃŇĽŉļŁĽķ ŃŋĹŇŋĽĹŌ
Our algorithm is an extended version of RD-based CNV detection that aims to mitigate the vast
target-to-target (and consequently gene-to-gene) heterogeneity of read coverage by
normalization procedures roughly corresponding to those employed in CNV detection methods
frommicroarray hybridization intensity data. ĉe overall workĚow of our method is shown in
Figure Ǌ.Ǌ.ǉ and described in greater detail in theMethods Ǌ.ǌ section. For a given gene in a given
sample (we will use the abbreviation GSS: Gene-Sample Site throughout the paper), we deėne
the read depth as the number of uniquely mapped reads whose Ǎ’ end falls within any of the
targeted exons within that gene. We compare this measurement with an expected read depth
(Eq. Ǌ.Ǌ, Methods Ǌ.ǌ.ǋ), based on a “gene aﬃnity” calculated frommeasured read depth for that
gene across all samples (to account for across-target read coverage variance due to target-speciėc
hybridization), and the overall read depth for the sample (to account for the variance of read
coverage due to the overall sequence quantity collected for the sample under examination). We
then use a Bayesian scheme, calculating the posterior probability for each copy number with prior
probablities estimated from previous study [ǉǐ] and the data likelihood computed based on the
data (SeeMethods Ǌ.ǌ.ǌ), to determine whether the measured coverage is consistent with normal
copy number (e.g. CN = Ǌ for autosomes), or aberrant copy number (i.e. homozygous deletion:
CN = ǈ, heterozygous deletion: CN = ǉ, or ampliėcation: CN > Ǌ). We have included two
algorithmic variants: One is suitable for CNV events that occur at a low allele frequency (i.e. in a
small fraction of the samples), and the other for capturing higher-frequency deletion events (see
Methods Ǌ.ǌ.ǐ).
ǊǍ
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Figure 2.2.1: A. Median Read Depth (MRD) is calculated for each sample, as a measure
of sample coverage (NA18523 shown). B. The gene aﬃnity is estimated for each gene as
the slope of the least-square-error linear ﬁt between MRD and RD for that gene (TRIM33
shown). C. Example of observed (magenta) and expected (green) read depth for three sam-
ples and four genes. The observed read depths were roughly half of the expected values for
genes TRIM33 and NRAS, in sample NA18523, and detected as deletions.
Ǌǎ
Ǌ.Ǌ.Ǌ DĵŉĵňĹŉ
In this study we analyzed the exon capture sequencing dataset collected by the ǉǈǈǈ Genomes
Project Exon Sequencing Pilot, including Ǒǋǉ genes (about ǌ.ǎƻ of the protein-coding genes in
the human genome) processed with Agilent liquid-phase and Nimblegen solid-phase capture
methods, and sequenced from ǎǑǏ individuals with Illumina paired-end and/or ǌǍǌ technologies.
ĉe samples in the dataset have been sequenced by four diﬀerent data collection centers
(Washington University, WU;Wellcome Trust Sanger Institute, SC; Broad Institute, BI; and
Baylor College of Medicine, BCM) using diﬀerent pairings of capture and sequencing
technologies (Table Ǌ.Ǌ.ǉ and Table Ǌ.Ǌ.Ǌ). Initially ǉ,ǈǈǈ genes were randomly selected by the
Exon Piolt Project from the CCDS [Ǐǐ, ǏǑ] database as targeted sequences. However, the capture
target designs used in the four production centers were signiėcantly diﬀerent. To eliminate the
inconsistency, the Pilot Project deėned a set of consensus exon target sequences by intersecting
the intial designs. ĉe consensus targets, Ǒǋǉ genes used in this study, has approximately
ǉ.ǌǋMbp in length, covering ǐǎ.ǉƻ coding regions in the initial ǉ,ǈǈǈ genes [ǐǈ]. As our method
relies on an estimate of the gene-speciėc hybridization aﬃnity, it requires that such aﬃnities are
consistent across all samples analyzed simultaneously. According to the principal component
analysis (PCA) of the observed read depths, (Figure Ǌ.Ǌ.ǊA, see Methods Ǌ.ǌ.ǉ), target and genes
aﬃnities are inconsistent across data from diﬀerent centers, and therefore we analyzed each
dataset separately. We only considered datasets with at least ǉǈǈ samples (SC, BI, BCM) so we
can obtain suﬃcient sample statistics across genes. Aěer ėltering out genes and samples that did
not meet our minimum read depth requirements (see Methods Ǌ.ǌ.Ǌ), we were leě with the
following datasets: SC (ǐǎǊ genes in ǉǈǎ individuals sequenced with Illumina), BI (ǏǋǑ genes in
ǉǉǈ samples sequenced with Illumina), and BCM (ǌǋǑ genes in ǋǌǑ samples sequenced with
ǌǍǌ) (Table Ǌ.Ǌ.ǉ). ĉe number of genes that passed our ėlters was substantially lower in the
BCM dataset both due to lower overall ǌǍǌ coverage (see below), and because the longer ǌǍǌ
reads result in lower RD (fewer reads) when compared to shorter Illumina reads, even at
ǊǏ
Table 2.2.1: Properties of datasets from diﬀerent sequencing centers
SC BCM BI WU
Total sample count ǉǉǏ ǋǍǊ ǉǎǉ Ǒǋ
Sample count aěer quality control ǉǈǎ ǋǌǑ ǉǉǈ ǐǊ
Technology Illumina ǌǍǌ Illumina Illumina
Duplicate rate ǈ.Ǌǉ ǈ.ǋ ǈ.Ǎ ǈ.ǏǊ
Mapping quality (mean) Ǎǈ ǋǋ ǌǍ Ǎǉ
Base coverage (mean ± standard deviation) Ǎǎ ± ǋǌ Ǌǋ ± ǉǊ Ǐǈ ± ǎǉ ǊǑ ± Ǒ
Read depth per gene (mean ± standard
deviation) ǊǋǈǑ ± ǋǉǎǎ ǉǈǎ ± ǉǏǉ ǉǋǊǑ ± ǊǈǍǋ ǑǏǏ ± ǉǋǐǊ
MRD (mean ± standard deviation) ǉǏǉǈ ± ǉǈǏǋ ǑǏ ± ǍǊ ǉǈǏǈ ± ǐǈǋ ǍǑǑ ± ǉǎǌ
Number of exons ǐǉǏǌ ǐǉǏǌ ǐǉǏǌ ǐǉǏǌ
Exons overlapped with segmental
duplication regions ǌǍǐ (Ǎ.ǎƻ) ǌǍǐ (Ǎ.ǎƻ) ǌǍǐ (Ǎ.ǎƻ) ǌǍǐ (Ǎ.ǎƻ)
Number of genes (passing QC) ǐǎǊ ǌǋǑ ǏǋǑ ǉ
Genes overlapped with segmental
duplication regions ǊǑ (ǋ.ǋƻ) ǉǉ(Ǌ.Ǎƻ) Ǌǋ(ǋ.ǉƻ) ǈ(ǈ.ǈƻ)
Over-dispersion factor (mean ± standard
deviation) Ǐ.Ǒ ± ǐ.Ǌ Ǌ.ǉ ± ǉ.ǉ ǎ.ǌ ± Ǎ.Ǎ N/A
Quality index (mean ± standard deviation) Ǒ.ǌ ± ǐ.ǐ Ǎ.Ǎ ± Ǌ.ǋ Ǐ.ǎ ± Ǎ.ǎ N/A
Expected detection sensitivity based on
quality index ǈ.ǌǎ ǈ.Ǌ ǈ.ǌǉ N/A
Number of calls h = Ƥ:ƪƩ either with or
without a neighboring call ǋǎ ǌ Ǎǎ N/A
Number of calls h = Ƥ:ƥ either with a
neighboring call ǉǏ ǈ ǉǉ N/A
Ǌǐ
Table 2.2.2: Data characterized by sequencing center and population
SC
CEU CHB JPT TSI YRI
Number of samples ǉǐ ǉǌ Ǒ Ǎǉ ǉǌ
Male/Female Ǒ/Ǒ Ǎ/Ǒ Ǎ/ǌ Ǌǌ/ǊǏ Ǌ/ǉǊ
Average read depth per gene ǉǎǏǑ ǉǏǈǉ ǉǍǑǏ ǉǎǉǏ ǉǐǎǍ
Read Length ǋǎ ǋǎ ǋǎ ǋǎ ǋǎ
BCM
CEU CHB CHD JPT LWK YRI
Number of samples ǌǈ ǎǊ Ǐǐ ǉǎ ǉǈǐ ǌǍ
Male / Female Ǌǈ/Ǌǈ ǉǍ/ǌǏ ǋǐ/ǌǈ Ǎ/ǉǉ Ǎǉ/ǍǏ ǊǊ/Ǌǋ
Average read depth per gene ǉǏǐ ǉǋǉ ǉǏǉ Ǌǌǋ ǉǊǐ ǉǎǍ
Read length ǊǍǐ ǋǊǋ ǋǋǑ ǋǈǈ ǋǋǎ ǋǊǊ
BI
CEU CHB CHD JPT YRI
Number of samples ǉǎ ǉǋ Ǌǐ ǋǌ ǉǑ
Male / Female Ǒ/Ǐ ǉǉ/Ǌ ǉǊ/ǉǎ ǉǎ/ǉǐ ǉǊ/Ǐ
Average read depth per gene ǉǎǊǋ ǉǎǋǉ ǉǎǏǍ ǉǉǈǌ ǉǎǉǊ
Read length Ǐǋ ǏǍ Ǐǌ ǏǍ Ǐǎ
Population abbreviations:
CEU—Utah residents with Northern andWestern European ancestry
CHB—Han Chinese in Beijing
CHD—Chinese in Denver, Colorado
JPT— Japanese in Tokyo, Japan
LWK—Luhya in Webuye, Kenya
TSI—Tuscans in Italy
YRI— Yoruba in Ibadan, Nigeria
equivalent base coverage.
Ǌ.Ǌ.ǋ SĵŁńŀĹ ķŃŋĹŇĵĻĹ ĵłĸ ĻĹłĹ ĵĺĺĽłĽŉĽĹň
As a metric of coverage for each sample, we calculated the sample-speciėc median gene RD,
referred to as “Median Read Depth” (MRD); see Figure Ǌ.Ǌ.ǉA andMethods Ǌ.ǌ.ǋ. MRDwas
highest for the SC samples (ǉ,Ǐǉǈ ± ǉ,ǈǏǋ, median ǉ,ǌǑǉ reads/gene; data presented as mean ±
standard deviation), see Figure Ǌ.Ǌ.ǊB. MRDwas somewhat lower for the BI samples (ǉ,ǈǏǈ ±
ǊǑ
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Figure 2.2.2: A. Principal component analysis of a “mixed” read depth matrix built with
data from 3 diﬀerent sequencing centers, SC (Wellcome Trust Sanger Institute), BI (Broad
Institute) and BCM (Baylor College of Medicine). Each sample is represented as a point in
the plot, with the ﬁrst principal component plotted vs. the second principal component. Sam-
ples from diﬀerent sequencing centers cluster separately from each other within this space,
suggesting signiﬁcant diﬀerences in the gene aﬃnities among these three datasets. B. Dis-
tributions of MRD for each of the BCM, BI and SC samples C. Histogram of RD across all
GSSs in the three datasets. D. Histogram of gene aﬃnities across genes within each of the
three datasets. E. Distributions of the RD over-dispersion factor (ODF) in our data.
ǋǈ
ǐǈǋ, median ǐǎǈ reads/gene), and much lower in the BCM dataset (ǑǏ ± ǍǊ, median ǐǏ
reads/gene). As mentioned above, RD (distributed as in Figure Ǌ.Ǌ.ǊC) is not determined by
base coverage alone. Base coverage was highest in the BI data (Ǐǈ ± ǎǉ, median Ǎǎ reads/base),
followed by SC (Ǎǎ ± ǋǌ, median Ǎǈ reads/base). ĉemuch lower RD in the ǌǍǌ reads from
BCM corresponds to only somewhat lower base coverage (Ǌǋ ± ǉǊ, median Ǌǉ reads/base).
For each target we deėne a quantity, the “target aﬃnity”, intended to describe the number of
reads (RD) being mapped to a given target, relative to the sample-speciėc MRD over all capture
targets. Analogously, we deėne the gene-speciėc aﬃnity as the ratio of the number of reads (RD)
mapped to the targets (exons) belonging to that gene and the gene-speciėc MRD for that same
sample (seeMethods Ǌ.ǌ.ǋ, Figure Ǌ.Ǌ.ǊD). In general, tighter distributions of aﬃnities, with
mean and median as close to ǉ as possible, are desirable because these correspond to more even
target coverage. ĉe observed gene aﬃnities for our datasets (Figure Ǌ.Ǌ.ǊD) were as follows: SC
(ǉ.ǌǈ ± ǉ.ǌǋ, median ǉ.ǈǌ), BI (ǉ.Ǎǐ ± ǉ.ǍǑ, median ǉ.Ǌǈ), and BCM (Ǌ.ǎǋ ± ǋ.ǈǋ, median ǉ.Ǐǋ).
Because of the more favorable gene aﬃnities, we used the SC data as our primary dataset for
method development and experimental validations.
Ǌ.Ǌ.ǌ CNV ķĵłĸĽĸĵŉĹň ĸĹŉĹķŉĹĸ Ľł ŉļĹ ĸĵŉĵ
According to our Bayesian detection scheme, we call a heterozygous deletion event in a gene if the
posterior probability value of CN = ǉ, i.e. P(CN=ǉ | RD) ≥ hwhere h is a pre-deėned probability
cutoﬀ value. Similarly, a homozygous deletion is where P(CN=ǈ | RD) ≥ h. Although we
detected both deletions and ampliėcations in the analyzed datasets, deletion events (even when
in a heterozygous state) provide easier detectable signal than ampliėcations. For this reason we
only discuss deletion events here and report candidate ampliėcations in Table Ǌ.Ǌ.ǋ.
Using a cutoﬀ value h = ǈ.ǎǍ, we detected Ǒǎ deletion events in the three datasets (ǋǎ in SC, Ǎǎ
in BI, and ǌ in BCM), all heterozygous deletions (Table Ǌ.Ǌ.ǌ, Table Ǌ.Ǌ.Ǎ and Table Ǌ.Ǌ.ǎ). ĉe
top ranked deletions are shown in Figure Ǌ.Ǌ.ǋA. Most of the events were found in the Tuscan
population, which constituted about half of the sample set. A subset of ǉǈ of ǋǎ gene deletions in
ǋǉ
Table 2.2.3: Gene duplication calls in the SC dataset (PP: posterior probability)
Population Sample Gene name Chr Start [bp] End [bp] PP RDobs RDexp
CEU NAǉǊǋǌǐ CDǋǈǈLB ǉǏ ǏǈǈǋǈǌǏǊ ǏǈǈǋǑǉǑǍ ǉ ǎǋǐ ǌǊǈ
TSI NAǊǈǍǋǋ CLDNǉǈ ǉǋ ǑǍǈǈǋǈǈǑ ǑǍǈǊǐǊǎǑ ǉ Ǌǉǈǐ ǉǍǐǊ
CHB NAǉǐǍǊǎ SNRNPǊǏ Ǌ ǎǑǑǏǌǎǊǉ ǎǑǑǏǏǉǐǌ ǉ Ǎǋǈ ǋǐǋ
CHB NAǉǐǍǋǊ CESǉ ǉǎ ǍǌǌǈǉǑǋǈ ǍǌǌǊǌǌǎǐ ǉ Ǎǈǉ ǋǋǏ
TSI NAǊǈǏǍǊ NOMǉ Ǐ ǉǍǎǌǋǍǉǑǋ ǉǍǎǌǍǍǉǍǐ ǉ ǉǋǋǍ Ǒǎǎ
TSI NAǊǈǏǑǎ AHNAK ǉǉ ǎǊǈǌǈǏǑǊ ǎǊǈǍǑǊǋǐ ǉ Ǐǋǋǈ ǍǉǎǑ
TSI NAǊǈǏǑǎ ZNFǊǎǌ ǉǑ ǎǊǌǈǐǍǏǏ ǎǊǌǉǎǉǎǉ ǈ.ǑǑǑ ǉǊǏǎ ǐǐǐ
TSI NAǊǈǐǈǉ GPRǉǊǐ ǋ ǉǈǉǐǉǉǋǑǉ ǉǈǉǐǑǎǍǋǍ ǈ.ǑǑǐ ǉǌǏǌǏ ǐǊǎǍ
TSI NAǊǈǏǏǊ STXǉǎ Ǌǈ ǍǎǎǎǈǌǎǑ ǍǎǎǐǌǏǍǋ ǈ.ǑǑǐ Ǌǉǈǉ ǉǎǈǍ
TSI NAǊǈǏǎǑ MRPSǎ Ǌǉ ǋǌǌǉǑǍǉǉ ǋǌǌǋǎǏǏǈ ǈ.ǑǑǐ ǉǍǐǍ ǉǊǈǋ
TSI NAǊǈǏǏǌ ELAVLǌ ǉ ǍǈǋǐǋǊǉǎ ǍǈǌǋǑǌǋǏ ǈ.ǑǑǐ ǏǐǊ ǍǎǏ
TSI NAǊǈǐǈǌ CYPǊAǉǋ ǉǑ ǌǎǊǑǉǋǏǍ ǌǎǊǑǋǎǐǎ ǈ.ǑǑǏ ǉǊǐǑ Ǒǐǌ
TSI NAǊǈǏǏǌ CREBǍ Ǐ ǊǐǌǑǌǋǉǐ ǊǐǐǊǍǌǊǉ ǈ.ǑǑǎ ǉǌǋǍ ǑǍǌ
TSI NAǊǈǏǑǎ ZNFǋǊ ǉǈ ǌǋǌǍǑǍǈǌ ǌǋǌǎǉǍǐǏ ǈ.ǑǑǎ Ǒǉǉ ǎǌǎ
TSI NAǊǈǍǊǈ CǎorfǉǌǍ ǎ ǋǎǎǐǐǍǊ ǋǎǐǋǋǐǉ ǈ.ǑǑǍ ǊǈǉǍ ǉǎǈǉ
CEU NAǉǊǋǌǐ GDNF Ǎ ǋǏǐǍǉǍǉǈ ǋǏǐǏǈǎǌǏ ǈ.ǑǑǌ ǋǈǎ ǊǉǏ
CHB NAǉǐǍǎǉ PSMBǌ ǉ ǉǌǑǎǋǐǎǐǐ ǉǌǑǎǌǈǏǋǈ ǈ.Ǒǐǎ ǋǌǎǉ ǊǊǉǎ
CEU NAǉǊǍǌǎ DAZAPǊ ǉǊ ǌǑǑǊǈǋǑǌ ǌǑǑǊǊǍǈǑ ǈ.ǑǐǍ ǊǊǎǍ ǉǎǍǉ
TSI NAǊǈǏǍǊ AATF ǉǏ ǋǊǋǐǈǍǋǑ ǋǊǌǐǐǈǏǏ ǈ.ǑǏǎ ǉǉǍǏ ǐǌǋ
CEU NAǉǊǏǌǑ PAQRǍ ǉǍ ǎǏǌǋǑǌǏǌ ǎǏǌǐǋǊǉǍ ǈ.ǑǏǎ ǉǎǐǌ ǉǊǋǑ
TSI NAǊǈǏǎǑ BCLǊLǉǉ Ǌ ǉǉǉǍǑǏǏǑǌ ǉǉǉǎǋǐǊǏǑ ǈ.ǑǎǍ ǉǐǉǋ ǉǌǋǍ
TSI NAǊǈǐǈǌ PILĆ Ǐ ǑǑǐǈǑǎǈǋ ǑǑǐǋǍǌǎǎ ǈ.ǑǈǑ ǑǎǊ ǏǍǊ
TSI NAǊǈǍǐǑ CǐorfǐǍ ǐ ǉǉǐǈǉǑǎǎǌ ǉǉǐǈǊǌǉǊǉ ǈ.Ǒǈǋ ǉǌǏ Ǒǉ
TSI NAǊǈǏǍǊ CCćR ǌ ǊǎǈǑǊǋǍǐ ǊǎǉǈǈǑǐǏ ǈ.ǑǈǊ ǏǉǊ ǍǋǊ
JPT NAǉǐǑǏǋ HBGǊ ǉǉ ǍǊǏǐǐǊǈ ǍǍǊǋǋǊǑ ǈ.Ǒǈǉ ǌǉǍǉ ǋǈǑǌ
TSI NAǊǈǏǏǌ HIPKǉ ǉ ǉǉǌǊǑǐǏǏǐ ǉǉǌǋǉǏǎǍǏ ǈ.Ǒ ǊǋǏǌ ǉǎǊǎ
TSI NAǊǈǏǏǌ ODCǉ Ǌ ǉǈǌǑǐǋǈǉ ǉǈǍǈǊǎǈǑ ǈ.ǐǑǏ ǉǌǐǑ ǑǋǍ
TSI NAǊǈǏǑǎ STBDǉ ǌ ǏǏǌǌǎǑǌǏ ǏǏǌǍǈǉǏǏ ǈ.ǐǐǍ ǑǏǐ ǎǎǌ
TSI NAǊǈǍǐǑ CRIPAK ǌ ǉǋǏǐǋǈǈ ǉǋǏǑǎǌǈ ǈ.ǐǏǏ Ǐǎ ǋǐ
YRI NAǉǑǉǐǑ PSMBǌ ǉ ǉǌǑǎǋǐǎǐǐ ǉǌǑǎǌǈǏǋǈ ǈ.ǐǍǋ ǊǎǊǊ ǊǈǑǈ
TSI NAǊǈǏǏǌ STXǉǎ Ǌǈ ǍǎǎǎǈǌǎǑ ǍǎǎǐǌǏǍǋ ǈ.ǐǉǉ ǑǌǑ Ǐǈǌ
JPT NAǉǐǑǐǈ CESǉ ǉǎ ǍǌǌǈǉǑǋǈ ǍǌǌǊǌǌǎǐ ǈ.Ǐǐǐ ǉǎǏǑ ǉǈǋǎ
TSI NAǊǈǏǏǌ PAQRǍ ǉǍ ǎǏǌǋǑǌǏǌ ǎǏǌǐǋǊǉǍ ǈ.Ǐǐǐ ǉǈǌǐ ǎǏǎ
CHB NAǉǐǍǎǉ CRNN ǉ ǉǍǈǎǌǐǎǑǌ ǉǍǈǎǍǉǋǋǋ ǈ.ǏǏǐ ǌǐǌǍ ǋǉǏǊ
TSI NAǊǈǏǏǌ DKKǌ ǐ ǌǊǋǍǈǏǏǍ ǌǊǋǍǋǏǊǈ ǈ.Ǐǎ ǌǑǋ ǋǎǊ
TSI NAǊǈǍǐǑ NOMǉ Ǐ ǉǍǎǌǋǍǉǑǋ ǉǍǎǌǍǍǉǍǐ ǈ.Ǐǌ ǉǈǍǊ ǐǈǉ
TSI NAǊǈǏǎǑ RNFǉǊǊ ǐ ǋǋǍǊǍǐǉǋ ǋǋǍǋǍǐǋǉ ǈ.Ǐǋǌ ǊǍǏǌ Ǌǈǈǌ
TSI NAǊǈǏǑǎ ZNFǍǊǉ ǉǐ ǊǈǐǑǎǎǏǌ ǊǉǉǐǌǑǈǐ ǈ.ǏǊǉ ǋǍǋǎ ǊǏǋǐ
TSI NAǊǈǏǎǑ VLDLR Ǒ ǊǎǊǍǌǍǋ ǊǎǋǉǌǑǑ ǈ.ǎǏǎ ǊǈǑǊ ǉǎǊǌ
ǋǊ
the SC dataset were found in two samples (NAǉǐǍǊǋ and NAǊǈǍǋǋ), clustered in a contiguous
string of deleted genes extending approximately ǋMbp on chromosome ǉ and ǉǏ, respectively, a
genomic deletion event that we were also able to ėnd in the ǉǈǈǈ Genomes Project
whole-genome Low Coverage Pilot data [ǉǍ] from the same samples.
Table 2.2.4: Gene deletion calls in the BI dataset (PP: posterior probability)
Population Sample Gene name Chr Start[bp] End[bp] PP RDobs RDexp
CHD NAǉǐǎǑǍ TPMǋ ǉ ǉǍǊǋǑǎǏǋǑ ǉǍǊǌǊǊǊǉǑ ǉ ǉǎǎ ǋǋǏ
JPT NAǉǑǈǎǎ TPMǋ ǉ ǉǍǊǋǑǎǏǋǑ ǉǍǊǌǊǊǊǉǑ ǉ ǉǎǑ Ǌǐǐ
CHD NAǉǐǎǐǏ RPLǊǏA ǉǉ ǐǎǎǉǋǊǍ ǐǎǎǋǑǊǑ ǉ Ǒǋ ǉǐǊ
JPT NAǉǐǑǐǋ POUǍFǉ ǎ ǋǉǊǌǈǋǍǏ ǋǉǊǌǉǐǈǋ ǉ ǉǊǊ ǊǍǎ
JPT NAǉǑǈǎǎ POUǍFǉ ǎ ǋǉǊǌǈǋǍǏ ǋǉǊǌǉǐǈǋ ǉ ǉǎǎ ǋǉǐ
JPT NAǉǑǈǎǎ RPLǊǏA ǉǉ ǐǎǎǉǋǊǍ ǐǎǎǋǑǊǑ ǉ ǉǈǎ Ǌǈǋ
CHD NAǉǐǎǐǏ TPMǋ ǉ ǉǍǊǋǑǎǏǋǑ ǉǍǊǌǊǊǊǉǑ ǉ ǉǍǍ ǊǍǐ
CHD NAǉǐǎǐǏ POUǍFǉ ǎ ǋǉǊǌǈǋǍǏ ǋǉǊǌǉǐǈǋ ǉ ǉǍǎ ǊǐǍ
JPT NAǉǑǈǍǌ TPMǋ ǉ ǉǍǊǋǑǎǏǋǑ ǉǍǊǌǊǊǊǉǑ ǉ ǉǋǍ Ǌǋǈ
CHD NAǉǐǎǑǍ POUǍFǉ ǎ ǋǉǊǌǈǋǍǏ ǋǉǊǌǉǐǈǋ ǉ ǉǑǌ ǋǏǉ
JPT NAǉǐǑǎǈ SETDǐ ǉǊ ǉǊǊǌǌǉǉǋǈ ǉǊǊǌǍǍǍǏǌ ǉ ǊǊǉ ǋǌǏ
CHD NAǉǐǉǎǌ RPLǊǏA ǉǉ ǐǎǎǉǋǊǍ ǐǎǎǋǑǊǑ ǉ ǉǊǑ ǊǊǋ
JPT NAǉǑǈǍǌ POUǍFǉ ǎ ǋǉǊǌǈǋǍǏ ǋǉǊǌǉǐǈǋ ǉ ǉǋǈ ǊǍǌ
CHD NAǉǐǎǑǍ SETDǐ ǉǊ ǉǊǊǌǌǉǉǋǈ ǉǊǊǌǍǍǍǏǌ ǉ ǉǌǊ ǋǈǑ
CHD NAǉǐǎǑǍ RPLǊǏA ǉǉ ǐǎǎǉǋǊǍ ǐǎǎǋǑǊǑ ǉ ǉǊǐ Ǌǋǐ
CHD NAǉǐǎǑǍ AKRǉBǉ Ǐ ǉǋǋǏǏǐǈǊǈ ǉǋǋǏǐǏǈǌǍ ǉ ǋǉǈ ǍǍǌ
CHD NAǉǐǉǎǌ HAXǉ ǉ ǉǍǊǍǉǊǐǏǌ ǉǍǊǍǉǌǐǈǉ ǉ Ǌǉǌ ǋǋǑ
CHD NAǉǐǎǐǏ SETDǐ ǉǊ ǉǊǊǌǌǉǉǋǈ ǉǊǊǌǍǍǍǏǌ ǉ ǉǊǍ ǊǋǏ
JPT NAǉǑǈǍǌ HFE ǎ ǊǎǊǈǉǋǊǎ ǊǎǊǈǊǌǋǋ ǉ Ǎǎ ǉǊǊ
JPT NAǉǐǑǐǋ RPLǊǏA ǉǉ ǐǎǎǉǋǊǍ ǐǎǎǋǑǊǑ ǈ.ǑǑ ǑǍ ǉǎǌ
JPT NAǉǐǑǐǋ TPMǋ ǉ ǉǍǊǋǑǎǏǋǑ ǉǍǊǌǊǊǊǉǑ ǈ.ǑǑ ǉǌǏ ǊǋǊ
JPT NAǉǑǍǎǉ TRIMǍǍ ǐ ǎǏǊǈǊǈǍǐ ǎǏǊǈǑǑǌǌ ǈ.ǑǑ ǉǉǑ ǉǑǋ
CHD NAǉǐǎǐǏ RBMSǉ Ǌ ǉǎǈǐǌǈǋǑǌ ǉǎǈǑǋǊǉǊǌ ǈ.ǑǑ ǋǋǌ ǍǏǍ
CHB NAǉǐǏǍǏ CRIPAK ǌ ǉǋǏǐǋǈǈ ǉǋǏǑǎǌǈ ǈ.ǑǑ ǋǊǏ ǎǎǑ
JPT NAǉǑǈǍǌ PSATǉ Ǒ ǐǈǉǈǑǌǏǉ ǐǈǉǉǋǋǉǑ ǈ.Ǒǐ ǉǌǈ ǊǍǋ
ǋǋ
Table 2.2.4: Gene deletion calls in the BI dataset — continuation from previous page
Population Sample Gene name Chr Start[bp] End[bp] PP RDobs RDexp
JPT NAǉǑǈǎǎ PSATǉ Ǒ ǐǈǉǈǑǌǏǉ ǐǈǉǉǋǋǉǑ ǈ.Ǒǐ ǉǑǈ ǋǉǏ
CHD NAǉǐǉǎǌ TPMǋ ǉ ǉǍǊǋǑǎǏǋǑ ǉǍǊǌǊǊǊǉǑ ǈ.Ǒǐ ǊǈǑ ǋǉǏ
JPT NAǉǑǍǎǐ ORǐAǉ ǉǉ ǉǊǋǑǌǍǉǏǍ ǉǊǋǑǌǎǉǌǉ ǈ.Ǒǐ ǌǏǉ Ǐǎǌ
JPT NAǉǑǈǎǎ ĆN ǉǊ ǉǊǑǑǊǋǋǋǌ ǉǊǑǑǊǎǌǊǌ ǈ.Ǒǐ ǊǊǑ ǌǎǊ
CHD NAǉǐǎǑǍ KLHLǉǊ ǉ ǊǈǉǉǊǐǊǐǌ ǊǈǉǉǎǈǑǉǋ ǈ.ǑǏ ǏǎǏ ǉǋǍǐ
JPT NAǉǑǈǎǎ SETDǐ ǉǊ ǉǊǊǌǌǉǉǋǈ ǉǊǊǌǍǍǍǏǌ ǈ.ǑǏ ǉǍǌ ǊǎǍ
JPT NAǉǑǈǎǎ RPSǉǍA ǉǎ ǉǐǏǈǎǐǐǎ ǉǐǏǈǏǑǋǎ ǈ.Ǒǎ ǐǋ ǉǎǉ
CHD NAǉǐǎǑǍ RPSǉǍA ǉǎ ǉǐǏǈǎǐǐǎ ǉǐǏǈǏǑǋǎ ǈ.Ǒǎ ǐǐ ǉǐǐ
CHD NAǉǐǎǐǏ KLHLǉǊ ǉ ǊǈǉǉǊǐǊǐǌ ǊǈǉǉǎǈǑǉǋ ǈ.Ǒǎ ǎǊǉ ǉǈǌǉ
JPT NAǉǐǑǐǋ SETDǐ ǉǊ ǉǊǊǌǌǉǉǋǈ ǉǊǊǌǍǍǍǏǌ ǈ.Ǒǎ ǉǊǈ Ǌǉǋ
JPT NAǉǐǑǐǋ DCTNǍ ǉǎ ǊǋǍǎǈǋǎǍ ǊǋǍǐǍǑǎǎ ǈ.Ǒǎ ǉǏǏ ǊǑǐ
JPT NAǉǐǑǐǋ EIFǊBǍ ǋ ǉǐǍǍǈǈǋǋǋ ǉǐǍǍǈǑǋǏǊ ǈ.Ǒǌ ǐǍǎ ǉǌǐǊ
CHD NAǉǐǎǐǏ ARGǊ ǉǌ ǎǏǉǐǏǐǍǍ ǎǏǉǐǏǑǍǉ ǈ.Ǒǌ Ǌǐ ǎǊ
CHD NAǉǐǎǑǍ PSATǉ Ǒ ǐǈǉǈǑǌǏǉ ǐǈǉǉǋǋǉǑ ǈ.Ǒǋ ǊǊǉ ǋǏǉ
CHD NAǉǐǎǑǍ RBMSǉ Ǌ ǉǎǈǐǌǈǋǑǌ ǉǎǈǑǋǊǉǊǌ ǈ.Ǒ ǌǌǊ ǏǍǈ
JPT NAǉǑǍǎǉ ORǐAǉ ǉǉ ǉǊǋǑǌǍǉǏǍ ǉǊǋǑǌǎǉǌǉ ǈ.ǐǑ ǊǍǌ ǌǎǎ
YRI NAǉǑǊǌǏ TIMMǐB ǉǉ ǉǉǉǌǎǉǊǊǑ ǉǉǉǌǎǊǎǍǏ ǈ.ǐǐ ǌǈ ǐǑ
CHD NAǉǐǉǎǌ POUǍFǉ ǎ ǋǉǊǌǈǋǍǏ ǋǉǊǌǉǐǈǋ ǈ.ǐǍ ǊǊǎ ǋǌǑ
CHD NAǉǐǉǎǌ KLHLǉǊ ǉ ǊǈǉǉǊǐǊǐǌ ǊǈǉǉǎǈǑǉǋ ǈ.ǐ ǐǈǋ ǉǊǏǎ
CHD NAǉǐǉǎǌ SETDǐ ǉǊ ǉǊǊǌǌǉǉǋǈ ǉǊǊǌǍǍǍǏǌ ǈ.ǏǑ ǉǐǉ ǊǑǉ
CHD NAǉǐǎǐǏ RPSǉǍA ǉǎ ǉǐǏǈǎǐǐǎ ǉǐǏǈǏǑǋǎ ǈ.ǏǑ ǐǉ ǉǌǌ
JPT NAǉǑǈǎǎ EIFǊBǍ ǋ ǉǐǍǍǈǈǋǋǋ ǉǐǍǍǈǑǋǏǊ ǈ.Ǐǐ ǉǉǋǏ ǉǐǌǈ
JPT NAǉǑǍǎǐ GABAĆPLǊ ǉ ǉǍǏǎǏǎǉǏǋ ǉǍǏǎǏǎǎǋǉ ǈ.Ǐǎ ǊǍǌ ǌǏǎ
JPT NAǉǑǍǎǈ ORǐAǉ ǉǉ ǉǊǋǑǌǍǉǏǍ ǉǊǋǑǌǎǉǌǉ ǈ.ǏǍ ǎǉǌ ǉǉǉǑ
JPT NAǉǑǈǍǐ RPLǊǏ ǉǏ ǋǐǌǈǌǊǑǌ ǋǐǌǈǐǌǎǋ ǈ.Ǐǋ ǋǍǎ Ǎǉǐ
CHD NAǉǐǎǑǑ SDPR Ǌ ǉǑǊǌǈǐǐǑǌ ǉǑǊǌǉǑǐǑǎ ǈ.ǏǊ ǍǊǌ ǉǈǋǋ
JPT NAǉǐǑǐǋ SPRRǊG ǉ ǉǍǉǋǐǐǑǐǑ ǉǍǉǋǐǑǊǉǈ ǈ.ǎǏ ǐǉ ǉǌǏ
JPT NAǉǑǈǎǎ SPRRǊG ǉ ǉǍǉǋǐǐǑǐǑ ǉǍǉǋǐǑǊǉǈ ǈ.ǎǏ ǉǈǍ ǉǐǊ
JPT NAǉǑǈǎǎ RBMSǉ Ǌ ǉǎǈǐǌǈǋǑǌ ǉǎǈǑǋǊǉǊǌ ǈ.ǎǏ ǌǈǌ ǎǌǊ
JPT NAǉǑǈǍǌ EIFǊBǍ ǋ ǉǐǍǍǈǈǋǋǋ ǉǐǍǍǈǑǋǏǊ ǈ.ǎǏ ǐǎǑ ǉǌǏǈ
ǋǌ
Table 2.2.4: Gene deletion calls in the BI dataset — continuation from previous page
Population Sample Gene name Chr Start[bp] End[bp] PP RDobs RDexp
CHD NAǉǐǎǑǍ ĆN ǉǊ ǉǊǑǑǊǋǋǋǌ ǉǊǑǑǊǎǌǊǌ ǈ.ǎǎ ǊǑǈ ǍǋǑ
When two or more gene deletions are detected in close proximity, it is likely that these events
are part of a single, longer genomic deletion spanning the genes. With this in mind, we searched
the sequenced genes for deletion events at a lower probability cutoﬀ value (h = ǈ.ǉ), but required
that an immediate neighbor of a candidate gene be located within ǋMbp and also show evidence
for a deletion at the same probability cutoﬀ. ĉis procedure produced ǉǏ heterozygous deletion
calls in the SC dataset, ǉǉ calls in the BI dataset (but no such calls were made in the BCM
dataset). ĉe union of both callsets (i.e. those made with and without use of neighboring
information) resulted in a total of ǉǈǏ unique deletion events (ǌǉ in SC dataset, ǎǊ in BI, and ǌ in
BCM). We note that none of the events we detected in our data were at high allele frequency. In
fact, even the most “common” events were only present in two samples, as heterozygotes.
Ǌ.Ǌ.Ǎ Cĵŀŀ-ňĹŉ ĵķķŊŇĵķŏ ĵňňĹňňŁĹłŉ
To assess the accuracy of deletion calls made in the SC dataset, researchers from Stanford
University ( Dr. Fabian Grubert and Dr. Alexander Urban) helped me perform experimental
validations on calls made with posterior probability ≥ǈ.ǎǍ without neighbor information, using
quantitative PCR (qPCR) (seeMethods Ǌ.ǌ). ĉe validation results are summarized in
Figure Ǌ.Ǌ.ǋB. Many of the CNV calls submiĨed for qPCR validation are not given a conclusive
results. ĉis is gernerally caused by some limitations of this technologies such as the high
similarity between the test DNA fragments and the target template and the defective design of the
primers [ǐǉ] Of the ǋǎ calls made, we evaluated Ǌǎ. All ǊǊ calls with posterior probability ≥ǈ.ǑǍ
and ǌ out of ǉǊ calls (randomly selected) with posterior probability between ǈ.ǎǍ and ǈ.ǑǍ were
ǋǍ
Table 2.2.5: Gene deletion calls in the SC dataset (PP: posterior probability)
Population Sample Gene name Chr Start [bp] End [bp] PP RDobs RDexp
YRI NAǉǐǍǊǋ BCLǊLǉǍ ǉ ǉǉǌǊǊǍǊǎǐ ǉǉǌǊǋǉǍǊǈ ǉ Ǎǋǋ ǉǉǍǐ
YRI NAǉǐǍǊǋ HIPKǉ ǉ ǉǉǌǊǑǐǏǏǐ ǉǉǌǋǉǏǎǍǏ ǉ ǊǍǋǑ ǍǊǏǊ
TSI NAǊǈǍǋǋ GLODǌ ǉǏ ǎǉǈǉǎǋ ǎǋǊǊǌǍ ǉ ǉǋǊǊ ǊǊǑǍ
TSI NAǊǈǍǋǋ CǉQBP ǉǏ ǍǊǏǏǈǍǑ ǍǊǐǊǋǉǏ ǉ ǏǑǋ ǉǌǉǎ
TSI NAǊǈǍǋǋ CǉǏorfǑǉ ǉǏ ǉǍǎǊǌǉǌ ǉǍǎǋǐǑǈ ǉ ǋǎǑ ǍǏǌ
YRI NAǉǐǍǊǋ NĆS ǉ ǉǉǍǈǍǊǎǏǑ ǉǉǍǈǎǈǋǈǌ ǉ ǏǈǊ ǉǌǎǊ
YRI NAǉǐǍǊǋ TRIMǋǋ ǉ ǉǉǌǏǌǉǏǑǋ ǉǉǌǐǈǐǍǋǋ ǉ Ǌǎǉǈ ǍǊǊǍ
TSI NAǊǈǍǋǋ TRPVǋ ǉǏ ǋǋǎǋǑǎǉ ǋǌǈǌǐǑǌ ǉ ǋǋǎǍ ǍǊǏǍ
TSI NAǊǈǏǏǌ PTMAPǉ ǎ ǋǈǏǊǍǎǏǉ ǋǈǏǊǐǎǏǉ ǉ ǉǋǊ Ǌǎǈ
TSI NAǊǈǏǑǎ SNRNPǊǏ Ǌ ǎǑǑǏǌǎǊǉ ǎǑǑǏǏǉǐǌ ǈ.ǑǑǐ ǉǈǍ ǉǑǌ
TSI NAǊǈǐǈǏ HISTǉHǊBC ǎ ǊǎǊǋǉǏǋǉ ǊǎǊǋǊǉǉǉ ǈ.ǑǑǐ ǌǊ Ǒǈ
TSI NAǊǈǏǏǊ ULBPǉ ǎ ǉǍǈǋǋǉǌǋǎ ǉǍǈǋǋǊǑǍǌ ǈ.ǑǑǏ ǉǈǌ ǊǈǍ
TSI NAǊǈǐǈǏ CYPǊAǉǋ ǉǑ ǌǎǊǑǉǋǏǍ ǌǎǊǑǋǎǐǎ ǈ.ǑǑǎ ǉǊǎ Ǌǈǌ
YRI NAǉǐǍǈǐ PTMAPǉ ǎ ǋǈǏǊǍǎǏǉ ǋǈǏǊǐǎǏǉ ǈ.ǑǑǊ ǉǌǍ Ǌǋǈ
CEU NAǈǏǈǈǈ PSGǐ ǉǑ ǌǏǑǍǈǊǐǏ ǌǏǑǎǈǊǏǋ ǈ.ǑǑ ǊǑ Ǐǈ
CEU NAǉǉǐǑǋ PSGǐ ǉǑ ǌǏǑǍǈǊǐǏ ǌǏǑǎǈǊǏǋ ǈ.ǑǐǍ ǌǋ ǐǎ
TSI NAǊǈǏǏǉ PTMAPǉ ǎ ǋǈǏǊǍǎǏǉ ǋǈǏǊǐǎǏǉ ǈ.Ǒǐ Ǎǋǋ ǐǎǊ
TSI NAǊǈǏǏǋ CCK ǋ ǌǊǊǏǌǍǑǌ ǌǊǊǐǈǉǊǎ ǈ.ǑǏǉ ǊǐǊ ǌǏǌ
CEU NAǈǏǈǈǈ HMGNǌ ǎ ǊǎǎǍǋǌǉǌ ǊǎǎǍǋǎǐǎ ǈ.Ǒǎǎ ǎǐ ǉǋǊ
CEU NAǉǊǏǌǑ HMGNǌ ǎ ǊǎǎǍǋǌǉǌ ǊǎǎǍǋǎǐǎ ǈ.Ǒǎǎ ǉǍǎ Ǌǐǎ
TSI NAǊǈǏǏǊ AIFǉ ǎ ǋǉǎǑǊǈǐǎ ǋǉǎǑǊǊǎǊ ǈ.Ǒǎǌ Ǎǉ ǉǊǌ
CEU NAǉǊǋǌǐ DUSPǉǈ ǉ ǊǉǑǑǌǊǋǏǏ ǊǉǑǑǌǎǊǉǎ ǈ.ǑǎǊ ǉǍǍ ǊǌǊ
YRI NAǉǐǍǈǐ ULBPǉ ǎ ǉǍǈǋǋǉǌǋǎ ǉǍǈǋǋǊǑǍǌ ǈ.Ǒǌǉ ǌǈ ǏǑ
YRI NAǉǐǍǊǋ PPMǉJ ǉ ǉǉǋǈǍǎǉǉǎ ǉǉǋǈǍǏǏǍǎ ǈ.ǐǑǉ Ǎǎǈ ǑǊǌ
TSI NAǊǈǐǈǏ POUǍFǉ ǎ ǋǉǊǌǈǐǐǌ ǋǉǊǌǉǐǈǋ ǈ.ǐǑǉ ǉǊǌ ǉǑǋ
TSI NAǊǈǏǏǊ SERPINAǉǉ ǉǌ ǑǋǑǏǐǎǑǎ ǑǋǑǐǌǐǎǌ ǈ.ǐǐǑ Ǐǐǎ ǉǊǌǋ
CEU NAǈǏǈǈǈ KRTǉǐPǉǑ ǉǊ ǍǉǎǋǈǋǏǑ ǍǉǎǋǊǋǑǋ ǈ.ǐǐǏ ǐǍ ǉǏǌ
CEU NAǉǊǋǌǐ ULBPǉ ǎ ǉǍǈǋǋǉǌǋǎ ǉǍǈǋǋǊǑǍǌ ǈ.ǐǏǑ ǌǑ ǐǐ
YRI NAǉǐǍǊǋ RHOC ǉ ǉǉǋǈǍǌǋǈǐ ǉǉǋǈǍǍǍǊǑ ǈ.ǐǎǏ ǍǍǏ ǑǍǍ
CEU NAǉǊǋǌǐ STBDǉ ǌ ǏǏǌǌǎǑǌǏ ǏǏǌǍǈǉǏǏ ǈ.ǐǋǑ Ǌǌǎ ǋǑǍ
CEU NAǈǏǈǈǈ POUǍFǉ ǎ ǋǉǊǌǈǐǐǌ ǋǉǊǌǉǐǈǋ ǈ.ǐǊǋ ǉǈǎ ǉǎǑ
CEU NAǉǊǏǌǑ SNRNPǊǏ Ǌ ǎǑǑǏǌǎǊǉ ǎǑǑǏǏǉǐǌ ǈ.ǏǏǍ ǉǌǊ Ǌǉǎ
TSI NAǊǈǏǍǊ POUǍFǉ ǎ ǋǉǊǌǈǐǐǌ ǋǉǊǌǉǐǈǋ ǈ.ǏǊǋ Ǐǎ ǉǌǊ
TSI NAǊǈǐǈǏ HISTǉHǊBO ǎ ǊǏǑǎǑǊǊǈ ǊǏǑǎǑǎǈǈ ǈ.ǏǊǋ ǌǐ ǐǐ
TSI NAǊǈǍǐǑ POUǍFǉ ǎ ǋǉǊǌǈǐǐǌ ǋǉǊǌǉǐǈǋ ǈ.ǎǑǏ ǎǉ ǉǉǏ
TSI NAǊǈǏǐǎ NPSRǉ Ǐ ǋǌǐǐǌǊǉǋ ǋǌǐǐǌǋǊǉ ǈ.ǎǏǐ Ǎǉ ǐǐ
Table 2.2.6: Gene deletion calls in the BCM dataset (PP: posterior probability)
Population Sample Gene name Chr Start [bp] End [bp] PP RDobs RDexp
LWK NAǉǑǋǍǍ MBDǍ Ǌ ǉǌǐǑǋǊǏǑǐ ǉǌǐǑǐǎǑǐǈ ǈ.ǑǑǑ ǎǉǐ ǑǏǋ
CHD NAǉǏǑǏǈ MTERFDǊ Ǌ Ǌǌǉǎǐǌǈǐǎ ǊǌǉǎǐǏǑǐǊ ǈ.ǑǑǎ ǊǍǍ ǋǑǋ
CHB NAǉǐǎǉǐ GABAĆPLǊ ǉǎ ǏǌǉǍǑǌǋǎ ǏǌǉǎǐǏǎǐ ǈ.ǐ Ǎǐ ǑǑ
CHD NAǉǐǉǋǍ PSMBǌ ǉ ǉǌǑǎǋǐǎǐǐ ǉǌǑǎǌǈǑǊǑ ǈ.ǏǊǑ ǋǑǈ ǎǈǍ
ǋǎ
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Figure 2.2.3: A. Top-ranked (by posterior probability) deletion events in the SC dataset. B.
Validation results for diﬀerent callsets (left — without neighboring information, right — with
use of neighboring information). Green denotes events positively validated either in our exper-
iments or as known events [18]; red — calls validated negatively in our experiments; yellow —
calls without validation status (not submitted for validation or validation experiments with-
out conclusive outcomes). C. Detection sensitivity as a function of number of samples. D.
Sensitivity of detecting common CNV as a function of the deleted allele frequency.
ǋǏ
Table 2.2.7: Validation results
Posterior>=ǈ.ǑǍ
without neighbor
information
ǈ.ǎǍ<=Posterior<ǈ.ǑǍ
without neighbor
information
Posterior>=ǈ.ǉ
with neighbor
information
Validated per previous
publication ǌ Ǌ Ǐ
Validated positively de novo ǉǉ ǉ Ǐ
Validated inconclusively de novo ǌ ǉ ǈ
Validated negatively de novo ǋ ǈ ǈ
SubmiĨed for validation but
without result
ǈ ǉǈ ǋ
Total calls ǊǊ ǉǌ ǉǏ
submiĨed for validation. A set of ǎ were considered positively validated as they appeared in an
earlier publication [ǉǐ] and Ǌǈ were validated de novo using qPCR.ĉe qPCR validations
produced positive results for ǉǊ calls (measured fold change <ǈ.Ǐ) and negative results for ǋ calls
(measured fold change >ǈ.ǐ). ĉe validation results for the remaining Ǎ were inconclusive. All the
ǉǏ neighbored calls with posterior probability ≥ǈ.ǉ were selected for validation. A set of Ǐ were
considered valid per previous publication [ǉǐ], Ǐ were positively validated de novo and none was
found invalid; validation was not obtained for the remaining ǋ. ĉe union of those two callsets
counted ǌǉ calls and ǋǊ of them were evaluated. Among these ǋǊ calls Ǐ were considered
positively validated per previous publication [ǉǐ], ǉǌ were positively validated de novo, ǋ were
invalidated, Ǎ were inconclusive and ǋ did not obtain the validation results. ĉe numbers of
validated calls are presented in Table Ǌ.Ǌ.Ǐ. ĉe selection procedure for site validation was as
follows: (ǉ)We selected sites for validation (in some categories, all candidates, in others, a
random selection); (Ǌ) we searched the literature [ǉǐ], and removed from the validation list
events that we found as validated in one of the publications we consulted; (ǋ) events that
remained on the list were sent for experimental validation. ĉe overall FDR for the union of calls
made with and without neighboring information can be estimated as ǉǊ.Ǎƻ (ǋ/Ǌǌ).
ǋǐ
Ǌ.Ǌ.ǎ SĹłňĽŉĽŋĽŉŏ
We performed simulations to assess the detection eﬃciency of our method, both for individual
gene and for pairs of neighboring genes deletions. Speciėcally, in each sample we randomly
selected (ǉ) Ǎ out of ǐǎǊ genes in one simulation and (Ǌ) Ǎ pairs of neighboring genes in another
simulation. In the selected genes we down-sampled the actual read depth seen in the
experimental data by a factor of Ǌ to simulate a heterozygous deletion. ĉe results of those
simulations are presented in Figure Ǌ.Ǌ.ǋC. Of the Ǎǋǈ gene deletions, we detected ǊǋǏ (ǌǍƻ). Of
the Ǎǋǈ gene-pair deletions we detected ǊǐǏ (Ǎǌƻ). We also performed simulations on smaller
subsets of the original ǉǈǎ samples to assess the impact of sample size on detection sensitivity.
Reduction of sample size did not substantially degrade detection sensitivity as long as the number
of samples was >Ǌǈ. ĉerefore, our detection eﬃciency is around ǌǍƻ without using neighboring
information and approximately Ǎǈ-ǍǍƻ with the use of neighboring information, in the SC
dataset.
In addition to simulations, we compared our dataset to a published study [ǉǐ]. ĉis study
reported ǉǊ heterozygous deletion events in samples and genes (in our terminology, GSS) that
were part of our analyzed dataset. We detected ǎ of these ǉǊ events, which is broadly consistent
with our overall sensitivity estimate.
Finally, we investigated our sensitivity to common events (see Methods Ǌ.ǌ.ǐ) using
simulations. Figure Ǌ.Ǌ.ǋD shows detection sensitivity as a function of gene-level aﬃnity: for a
gene aﬃnity value of ǉ.ǐ (representing the ǏǍth percentile of our data), sensitivity to common
events (allele frequency between ǉǈƻ and Ǒǈƻ) approaches ǌǈƻ. Note that the detection
eﬃciency starts to decrease at high allele frequency (>Ǐǈƻ) due to a reduction of the overall read
depth because more samples have a deletion and a corresponding depleted read depth signal. ĉe
estimated gene aﬃnity will be dominated by these deleted events. Instead of detecting these
deletion events, the samples with normal copy numbers will be detected as ampliėcations. We
can also see that the median gene aﬃnity is substantially lower than the mean because the
distribution of gene aﬃnity has a long tail at the high end (Figure Ǌ.Ǌ.ǊD). Since sensitivity is
ǋǑ
directly related to the gene aﬃnity, the simulated data with the substantially higher mean gene
aﬃnity (red) has beĨer sensitivity than with the substantially lower median gene aﬃnity (green).
Ǌ.Ǌ.Ǐ TļĹ łŊŁĶĹŇ Ńĺ CNV ĹŋĹłŉň Ľł ŉļĹ ňĵŁńŀĹň
We estimated the total number of gene deletions in the SC dataset from the number of detected
events (ǌǉ), the FDR (ǉǊ.Ǎƻ) and the detection eﬃciency (ǌǍƻ), as ~ǎǎ in total ǉǈǎ samples, or
a nominal ǈ.ǎǊ deletions per sample . By projecting the per-sample number, corresponding to
ǋ.Ǒƻ of the exome (ǐǎǊ genes of Ǌǉ,ǑǑǑ), onto the whole exome, our estimate for the average
number of genic deletion events is ǉǎ ± ǌ per sample. ĉis estimation is very close to that from a
large-scale whole-genome scanning CNV study with high-resolution CGH technology published
in Ǌǈǉǉ [ǉǐ]. In that study, ǎǉǐǏ heterozygous deletions were found in exon regions from ǌǍǈ
samples (on average, it is ~ǉǌ heterozygous deletions per exome). ĉis estimation is
representative for the whole-exome sequencing data since the ǉǈǈǈ Genomes Exon Pilot Project
randomly selected all the exon targets from the CCDS collection. Our gene set is therefore a
quasi-random sampling of known human genes, with no intentional enrichment for any given
gene family. Figure Ǌ.Ǌ.ǌA and Ǌ.Ǌ.ǌB show the distributions of exon length in the gene list used
for our analysis and the full human exome. ĉere is no signiėcant diﬀerence between these two
distributions: the median and the standard deviation of the exon length for our study are ǉǊǍ bp
and Ǌǋǎ bp, whereas the corresponding values for the whole exome are ǉǊǏ bp and Ǌǎǌ bp. ĉe
similarity of these two distributions suggests that our estimation of the number of events per
sample is unbiased and is representative for a whole-exome analysis.
Ǌ.Ǌ.ǐ DĹŉĹķŉĽŃł ĹĺĺĽķĽĹłķŏ ĵň ĵ ĺŊłķŉĽŃł Ńĺ ĸĵŉĵ ŅŊĵłŉĽŉŏ ĵłĸ ĸĵŉĵ ŅŊĵŀĽŉŏ
As discussed earlier, our algorithm’s sensitivity was ǌǍƻ at ǐǏ.Ǎƻ accuracy. Both sensitivity and
accuracy are considerably lower than achievable for SNP detection in the same datasets [ǉǍ]. ĉis
poses the more general question of how detection eﬃciency is inĚuenced by sample size, data
quantity, and data quality. Our simulations show that sensitivity only modestly depends on
ǌǈ
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Figure 2.2.4: A. Exon length distribution in the gene list used for our analysis (median: 125
bp, standard deviation: 236 bp). B. Exon length distribution of the whole exome (median:
127 bp, standard deviation: 264 bp). These two distributions are very similar to each other,
suggesting our estimation of the number of events per sample is unbiased and is representa-
tive for a whole-exome study.
sample size, above approximately Ǌǈ samples (Figure Ǌ.Ǌ.ǋC).
We found that the primary factors that determine detection eﬃciency are (ǉ) sequence
coverage, or more precisely, RD (higher RD supplies more statistical power to detect systematic
changes in coverage); (Ǌ) the level of over-dispersion of the RD distribution for individual genes
(the more the RD distribution departs from an expected Poisson distribution, the less one can rely
on the statistics); and (ǋ) the shape of the distribution of RD across all genes in the dataset,
determined by the gene aﬃnities (uneven distribution means that detection power is low in a
high fraction of the genes, but this eﬀect is not compensated by the extra coverage in other,
“over-sequenced” genes where detection eﬃciency is already high, see Figure Ǌ.Ǌ.ǍA. Favorable
scenarios therefore involve distributions in which all or most genes have suﬃcient RD for
detection).
For each gene, we compute a quality index (QI) taking into account the variance of the
expected read depth for that gene (assuming the ideal, Poisson distribution), RDexpected, and a
over-dispersion factor, ODF (seeMethod Ǌ.ǌ.Ǎ), that quantiėes the over-dispersion of RD
ǌǉ
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Figure 2.2.5: A. Distributions of the detection eﬃciency estimated from the quality index for
each gene-sample site. B. Theoretical detection eﬃciency (at posterior probability cutoﬀ h =
Ƥ:ƪƩ) as a function of expected read depth, plotted for various values of the over-dispersion
factor. C. Histograms of the quality index (QI) distribution in the three datasets. Overall, QI
was highest in SC: 9.4±8.8 (median 6.6); second highest in BI: QI = 7.6 ± 5.6 (median 6.2);
and lowest in BCM: QI = 5.5 ± 2.3 (median 5.0).
ǌǊ
Table 2.2.8: Nominal prior probabilities corresponding to the range of gene region copy
numbers derived from Conrad et al. 2010 [18]
Copy number Prior probability per gene
ǈ ƪ:Ƨƨ  ƥƤ ƨ
ǉ Ʀ:ƥƥ  ƥƤ Ƨ
Ǌ ƭ:ƭƪ  ƥƤ ƥ
ǋ Ʃ:ƧƬ  ƥƤ ƨ
ǌ ƪ:ƪƬ  ƥƤ ƨ
Ǎ Ƨ:Ʃƫ  ƥƤ Ʃ
ǎ ƫ:ƩƦ  ƥƤ ƪ
Ǐ ƥ:Ƨƭ  ƥƤ ƪ
ǐ Ƨ:ƪƥ  ƥƤ ƫ
Ǒ ƨ:Ƨƫ  ƥƤ Ƭ
relative to the Poisson expectation:
QI =
p
RDexpected
ODF
(Ǌ.ǉ)
QI is directly related to detection sensitivity, as shown in Figure Ǌ.Ǌ.ǍB. According to our
power calculations, for the posterior detection threshold value we used in this study (h = ǈ.ǎǍ),
sensitivity is completely diminished for genes with QI < Ǎ.ǉ. QI ≥ Ǐ.Ǌ is required to achieve Ǎǈƻ
sensitivity, and QI ≥ Ǒ.Ǎ to achieve Ǒǈƻ sensitivity. ĉis estimated sensitivity fromQI is made
only for heterozygous deletions. To achieve the same sensitivity for detecting higher copy
number variation (CN ≥ ǋ), higher QI value will be required since the diﬀerence of prior
probability between higher copy and normal copy (CN = Ǌ) is greater than that between
heterozygous deletion and normal copy (Table Ǌ.Ǌ.ǐ).
ĉe distributions of QI values in our three datasets are shown in Figure Ǌ.Ǌ.ǍC. Overall, QI was
highest in SC: Ǒ.ǌ ± ǐ.ǐ (median ǎ.ǎ); second highest in BI: QI = Ǐ.ǎ ± Ǎ.ǎ (median ǎ.Ǌ); and
lowest in BCM: QI = Ǎ.Ǎ ± Ǌ.ǋ (median Ǎ.ǈ). ĉe corresponding distributions of detection
eﬃciency values are shown in Figure Ǌ.Ǌ.ǍA. Because detection eﬃciency increases abruptly from
ǈ to almost ǉ over a narrow range of QI values (note the mapping between the vertical axes in
Figure Ǌ.Ǌ.ǍB), the distribution of detection sensitivity (Figure Ǌ.Ǌ.ǍA) is strongly bimodal, with
ǌǋ
the vast majority of GSS having either close to zero or close to ǉǈǈƻ sensitivity. Even in the SC
dataset with the highest overall QI values, in less than half of the GSS does the quantity and
quality of the data support >ǐǈƻ detection eﬃciency. ĉere was also very substantial variation
across samples: only ǉǍ of the ǉǈǎ SC samples had suﬃciently high coverage to support ≥ Ǒǈƻ
overall sensitivity, and in ǊǊ samples overall sensitivity was below ǉǈƻ.
Given that QI improves only with the square root of RD, over-dispersion can profoundly
inĚuence detection performance, as shown in Figure Ǌ.Ǌ.ǍB.ĉeODF values we chose for this
ėgure correspond to the ǊǍth, Ǎǈth and ǏǍth percentile, and the mean values (ODF = ǋ, Ǎ.Ǎ, ǉǈ,
and ǐ, respectively) in the SC dataset. Using the observed distribution of QI in the SC dataset, we
predict ǌǎƻ sensitivity, in good agreement with our estimate based on simulations. ĉeQI
formulation permits one to estimate CNV (or speciėcally in our case, heterozygous deletion)
detection power in any given exon capture dataset, based on the read mappings. One can also use
the formulation to calculate the amount of base coverage required for a given level of desired
power, to guide data collection. For example, using the distributions of QI values in the SC
dataset, one would need to collect an overall ǉǉǈ coverage, assuming ǋǎ bp reads, to achieve
ǎǈƻ detection power, and ǋǊǈ coverage to achieve ǐǈƻ detection power. However, if DNA
capture methods improved to support a median ODF = ǋ, assuming an accordingly scaled version
of the observed distribution of QI in the SC dataset, one would only need to collect ǋǋ coverage
for ǎǈƻ power, and Ǒǎ for ǐǈƻ power. It is important to also point out that, in the case of
whole-exome data, sensitivity would also improve just by virtue of the higher density of targeted
genes, if one were to integrate in one’s pipeline neighbor-gene based detection.
Ǌ.Ǌ.Ǒ FŊłķŉĽŃłň Ńĺ ĵĺĺĹķŉĹĸ ĻĹłĹň
Although function study is not our major goal for this research work, we still found some genes
aﬀected by CNVs in the callset that are correlated with human diseases. For example,
heterozygous deletions are detected at POUǍFǉ, a gene that is responsible for the self-renewal
activity and pluripotency of embryonic stem cells and germ cells [ǐǊ], in many Asian samples
ǌǌ
from both BI and SC datasets. ĉemutations of this gene and EWSRǉ together are reported to
play an important role in sarcomagenesis and tumor cell maintenance [ǐǋ]. Two genes from
BCLǊ familiy, BCLǊLǉǉ and BCLǊLǉǍ are detected as duplications and heterozygous deletions
recpectively in the SC dataset. BCLǊ family is well known as one of the regulators for
programmed cell death. When it dominants, the programmed cell death will be suppressed and
the cell can therefore survive [ǐǌ]. ĉe dysfunction of this gene is associated with many types of
cancers such as breast cancer [ǐǍ] and prostate cancer [ǐǎ]. Many other cancer-related genes are
discovered as CNVs in the callset as well, such as NĆS [ǐǏ], ODCǉ [ǐǐ] and CRIPAK [ǐǑ, Ǒǈ].
Besides cancers, genes associated with neurodegenerative genetic disorders are also seen. SETDǊ,
also known as HYPB (huntingtin yeast partner B), is involved in the modulation of chromatin
structure and may also bind to DNA promoters and interact with Pol II, thereby promoting
transcription [Ǒǉ]. ĉemutation of SETDǊ is associated with the pathogenesis of Huntington’s
disease [ǑǊ], which is characterized by a loss of striatal neurons, leading to brain deterioration
and, ultimately, death. Another gene in the detected in our callset, GDNF, a highly conserved
neurotrophic factor. ĉemajor function of the protein production of this gene is to promote the
survival and diﬀerentiation of dopaminergic neurons in culture and to prevent apoptosis of motor
neurons induced by axotomy [Ǒǋ]. ĉe dysfuction of this gene may lead to Parkinson’s disease, a
degenerative disorder of the central nervous system. HFE, a gene that econdes a membrane
protein that is responsible for regulating iron absorption, is invloved in the devlopment of
Alzheimer’s disease [Ǒǌ] since the iron imbalance may have impact on plaque formation, amyloid
processing, and expression of and response to inĚammatory agents. Many other
disease-correlated genes, such as TPMǋ (muscle weakness [ǑǍ]), DAZAPǊ (male
infertility [Ǒǎ]) and HAXǉ (neutropenia [ǑǏ]) are also seen in our callset. Due to the design of
ǉǈǈǈGP exon capture sequencing study, the phenotype data of all the samples are not available so
it is very hard for us to do any further functional studies of these detected CNVs. However, for
other large whole-exome sequencing projects that focus on functional studies, our method could
be potentially used for detecting events with signiėcant biological impact.
ǌǍ
Ǌ.ǋ DĽňķŊňňĽŃł
We have developed a novel, Bayesian method to identify CNVs in exon-capture data. We applied
this method (and a simple extension using neighbor-gene information) to the ǉǈǈǈ Genomes
Project Exon Sequencing Pilot dataset. We were able to achieve reasonable sensitivity (which is
limited by the quality of the dataset instead of our methodology) and speciėcity in a dataset that
was optimized for SNP discovery and, as discussed above, is far from ideal for CNV detection. As
new whole-exome sequencing data become easily available nowadays with higher coverage and
low or even none (single molecule sequencing) PCR bias, the detection eﬃciency of our method
should be signiėcantly improved based on our statistical analysis (quality index).
Krumm and his colleagues recently published a method, CoNIFER [Ǒǐ], that also used
read-depth signal to detect CNV in the exome capturing sequencing data. Like our method,
CoNIFER normalizes the read depth signal in order to discover the CNV. However, it is quite
diﬀerent for these two algorithms in the approach of calling samples copy number variants on the
basis that they present aberrant read depth. As we mentioned previously, our method deploys
speciėc models for copy numbers ǈ, ǉ, Ǌ, and is capable of detecting both rare, intermediate
frequency, and common CNV events. On the other hand, CoNIFER deploys singular value
decomposition (SVD) to remove noise from the read depth data, and interprets the ėrst “k”
singular values as noise in the data. ĉis approach may identify systematic variance in the data
caused by a high-frequency CNV event as noise and removes it. ĉerefore CoNIFER has limited
power for detecting commonCNV events. On the other hand, our method is capable of detecting
CNV events on the entire frequency spectrum, and is therefore more generally applicable.
ĉemain accomplishment of this work is that we provide a statistically rigorous algorithm for
CNV detection in exon capture data, backed by experimental validations, that can be applied to
the thousands of exomes sequenced to date in various medical projects, and to nascent and
on-going projects targeting increasingly higher numbers of samples. Our formulation allows
investigators to assess detection power in existing datasets and to take into account CNV
ǌǎ
detection power during experimental design for future datasets. We also uncovered >ǉǈǈ
heterozygous deletion events in the ǉǈǈǈ Genomes samples we examined, allowing us to estimate
the average number of heterozygous deletions per exome (as ~ǉǎ events per exome for a diploid
genome. See Results Ǌ.Ǌ.Ǐ). Because we focused on algorithm we only did some brief functional
assessment of these sites is beyond in this study. Nevertheless, these and other gene deletions that
will be found using our methods are very likely to uncover events with strong functional
signiėcance.
Ǌ.ǌ MĹŉļŃĸň
ĉe overall detection workĚow (shown in Figure Ǌ.Ǌ.ǉ) consists of ėve main steps: (ǉ)We
tabulate the observed read depth for every GSS. (Ǌ)We determine whether the distribution of
read depth for a speciėc gene distribute across samples should be modeled using simple uni-linear
ėt or using a more sophisticated tri-linear ėt. (ǋ) If the simple uni-linear ėt is found suitable, we
determine an expected read depth for every GSS under a null hypothesis of a normal copy
number, using a simple linear ėt model. (ǌ) Subsequently, we compare the observed read depth
for a GSS to the corresponding expectation , calculate a Bayesian posterior probability for each
copy number considered (CN = ǈ-Ǒ) and report events that pass the pre-deėned posterior
probability threshold with a non-normal CN. (Ǎ) If data do not allow for modeling using a simple
uni-linear ėt model, we perform a more sophisticated tri-linear ėt. ĉe tri-linear ėt directly
assigns copy number to every sample.
Ǌ.ǌ.ǉ OĶňĹŇŋĹĸ ŇĹĵĸ ĸĹńŉļ
Capture sequencing reads from the ǉǈǈǈ Genomes Project Exon Sequencing Pilot Project were
downloaded, in FASTQ format, from the ǉǈǈǈ Genomes Project DCC site:
hĨp://ǉǈǈǈgenomes.org. ĉe reads were mapped using theMOSAIK read mapping
program [ǍǏ], to the NCBI build ǋǎ.ǋ human reference genome. ĉe resulting read alignments
(in BAM format) were further processed to remove duplicate reads, and reads with lowmapping
ǌǏ
quality (<Ǌǈ) [ǍǏ].
Gene target regions were also downloaded from the ǉǈǈǈ Genomes Project site. For each GSS,
we determined RD as the number of distinct reads that had their ėrst (Ǎ’) base uniquely mapped
within an exon of that gene. ĉis resulted in a matrix of RD observations (illustrated in
Figure Ǌ.Ǌ.ǉC leě).
Ǌ.ǌ.Ǌ Dĵŉĵ ĺĽŀŉĹŇĽłĻ
We discarded all duplicate reads and all reads with mapping quality less than Ǌǈ. We also
discarded all the targets with median RD less than ǋǈ. Similarly, we discarded all the samples with
median RD less than ǋǈ. In ǌǍǌ-sequenced data, this led to discarding almost all targets and
samples; therefore we relaxed those criteria to Ǎ and ǉ, respectively. Additionally, we discarded all
the genes that failed to exhibit correlation between observed RD andMRD at rƦ ≥ ǈ.Ǐ.
Ǌ.ǌ.ǋ EŎńĹķŉĹĸ ŇĹĵĸ ĸĹńŉļ ĶĵňĹĸ Ńł ŊłĽ-ŀĽłĹĵŇ ĺĽŉ ĵłĸ ŉŇĽ-ŀĽłĹĵŇ ĺĽŉ
In the ėrst aĨempt, we use the simple uni-linear ėt; we calculate the expected read depth for
normal copy number (CN = Ǌ) as the product of a gene-speciėc capture aﬃnity value, αg, and a
sample-speciėc measure of read coverage, the median of read depths, MRDs, across all genes for
that sample:
RDgs = αg MRDs (Ǌ.Ǌ)
ĉe gene-speciėc capture aﬃnity (αg) is determined as the slope of a least-squares
zero-intercept linear ėt between the gene-speciėc read depth (RDgs) and the median read depth
(MRDs) for all samples (illustrated in Figure Ǌ.Ǌ.ǉB).ĉis procedure resulted in a matrix of RD
expectations (Figure Ǌ.Ǌ.ǉC right).
ĉe afore-mentioned procedure requires a single-line linear ėt between RDgs andMRDs. ĉe
quality of such a ėt is evaluated by comparing rƦ against a predetermined threshold (≥ǈ.Ǐ as
described before). When this indicates poor quality of the single-line linear ėt, we aĨempt to
ǌǐ
perform a tri-linear ėt.
BrieĚy, we aĨempted to minimize error function:
errorg =
X
s
min

(RDg;s   αg MRDs); (RDg;s   αgƦ MRDs); (RDg;s   Ƥ MRDs)
	
(Ǌ.ǋ)
where s iterates over samples and g indicates the gene in question. Note that the tri-linear ėt
directly assigns copy number to each GSS. Please see Common CNVs (Methods Ǌ.ǌ.ǐ) for more
detail.
Ǌ.ǌ.ǌ CŃńŏ łŊŁĶĹŇ ńŇŃĶĵĶĽŀĽŉĽĹň
We used a Bayesian scheme to calculate the probability P(CNgs|RDgs) of a given copy number at
a given GSS, based on the observed read depth. We only considered CN = ǈ-Ǒ i.e. homozygous
deletion (CN = ǈ), heterozygous deletion (CN = ǉ), normal copy number (CN = Ǌ), and
ampliėcations of various magnitudes (CN > Ǌ). We assigned prior probabilities P(CNgs) to each
copy number based on CNV events reported in an earlier study [ǉǐ] (Table Ǌ.Ǌ.ǐ). We assumed
that, for each distinct CN, the observed RD obeys an over-dispersed Poisson distribution. Its
mean value for normal copy number (CN = Ǌ) is calculated according to (Eq. Ǌ.Ǌ) and for other
copy numbers it is proportionally scaled. ĉe standard deviation of the distribution includes an
over-dispersion factor (ODF) in the range of ǉ to Ǌǈ to account for over-dispersion (variance
beyond the level of Poisson Ěuctuations, see Method Ǌ.ǌ.Ǎ).
BrieĚy, to account for over-Poisson dispersion, we used observed RDgs and calculated
corresponding z-score under an assumption of an ideal Poisson distribution at every GSS.
Subsequently, we calculated a sample-speciėc standard deviation of that z-score for every sample
and annotated it as sample over-dispersion factor. Similarly, we calculated a gene-speciėc
standard deviation of z-score for every gene and annotated it as the gene-speciėc over-dispersion
factor. If the assumption of an ideal Poisson distribution were true, those sample- and
ǌǑ
gene-speciėc standard deviations should equal ǉ. Subsequently, we calculated the over-dispersion
factor for every GSS as a product of respective sample- and gene-speciėc ODFs. ĉeODF was
then normalized and assigned to ǉ if less than ǉ.
We used the over-dispersed Poisson distributions to calculate the data likelihoods P(RDgs|CN)
for all considered CN values. Finally, we used Bayesian method to estimate the posteriors for each
considered CN (Eq. Ǌ.ǌ).
P(CNgsjRDgs) = P(CN)  P(RDgsjCN)P
CN0 P(CN0)  P(RDgsjCN0)
(Ǌ.ǌ)
A CNV event is reported the posterior probability of a non-normal copy number is above a
pre-deėned threshold value, h.
Ǌ.ǌ.Ǎ IłňĽĻļŉ ĺŇŃŁ ĹŁńĽŇĽķĵŀ ĸĵŉĵ ĵłĸ ĵķķŃŊłŉĽłĻ ĺŃŇ ŃŋĹŇ-ĸĽňńĹŇňĽŃł
We performed a simulation to assess potential variability in the gene aﬃnities on the
over-dispersion. Using this data, we calculated expected read depth RDexpected for every GSS as
product of respective gene aﬃnity andMDR. Subsequently, we calculated read depth using
Poisson distribution with RDexpected as parameter. ĉe z-score calculated from that distribution
followed a normal distributionN(Ƥ; ƥ), as expected for an ideal case.
Subsequently, we randomly distorted the vector of gene aﬃnities; i.e. we drew a random
number from a normal distributionN(αg; Ƥ:ƥƩ  αg)to be used instead of the exact aﬃnity αg. With
increased variability in gene aﬃnities, the distribution becomes progressively wider; at a ǉǍƻ
increase in variability the results are comparable to the distribution of the empirically calculated
z-score (Figure Ǌ.ǌ.ǉ). ĉis result indicates that as liĨle as ǉǍƻ variability in gene aﬃnities is
enough to reproduce the distribution over-dispersion observed in the experimental data.
If we knewODF for every GSS in our data, we could correct for it, so that
RDobserved   RDexpected
c pRDexpected  N(Ƥ; ƥ) (Ǌ.Ǎ)
Ǎǈ
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Figure 2.4.1: To generate the simulated data, we introduced a normal random noise to
each target aﬃnity calculated from the real data with 15% of the value of the target aﬃn-
ity, N(α, 0.15α). The distribution of the z-score (RDobs RDexpp
RDexp
) from the simulated data (red)
is very similar to that of the real data (blue). Note that both z-score distributions from simu-
lated and real data are much wider (dispersed) than the ideal normal distribution (green) due
to the over-dispersion eﬀect.
Ǎǉ
where c is the sample-gene-speciėc correction factor for the over-dispersed Poisson eﬀect
(over-dispersion factor, ODF).
As indicated above, ODF remains constant over a range of coverage only under assumption of
mutual independence of subsequent runs. When the entire z-scorematrix is considered, that
assumption is obviously violated (i.e. RDs in diﬀerent genes in a sample are correlated by sharing
the sameMDR and RDs in a gene in diﬀerent samples are correlated by sharing the same gene
aﬃnity).
In the absence of a fundamental model describing interplay between gene aﬃnities varying
across genes, samples and machine runs, we developed an empirical procedure to account and
correct for over-dispersion.
We estimated the over-dispersion factor for each site according to the following steps. First we
calculated a z-scorematrix [zs;g],
zs;g =
observeds;g   expecteds;gp
expecteds;g
(Ǌ.ǎ)
from the observed read depth matrix [observeds;g] and expected read depth matrix [expecteds;g].
ĉen for every row and for every column in the ”z-score” matrix, we calculated their respective
standard deviations. ĉis procedure generated a column vector [cs;] of row (sample-speciėc)
standard deviations and a row vector [c;g] of column (gene-speciėc) standard deviations.
Subsequently, the over-dispersion factor matrix [cs;g]was calculated as:
cs;g =
cs;  c;g
mean(c;g)
(Ǌ.Ǐ)
If any over-dispersion factor was to fall below ǉ, it was assigned ǉ since no counting experiment
of independent trials should have a variance less than that of a Poisson distribution.
Once the over-dispersion factor was calculated, we could model data likelihood using a normal
distributionN(RDexptected; c 
p
RDexpected).
ǍǊ
Ǌ.ǌ.ǎ NĹĽĻļĶŃŇĽłĻ ĻĹłĹ ĸĹŀĹŉĽŃłň
A simple extension of the algorithm used neighboring gene deletion events as part of the
detection method. For the purpose of our algorithm, the genes were deemed “neighboring” if
they were located on the same chromosome, the segment between those genes was no longer
than ǋMbp and no gene was sequenced in between. In principle, when a gene has a deleted
neighbor, we should assume a higher prior probability of a deletion in the gene in question. Since
the posterior probability usually scales monotonically with the prior, for practical reasons we
assumed a lower Bayesian posterior probability threshold (h = ǈ.ǉ) to produce a preliminary list
of candidate events. Events on this list for which at least one of the two immediate neighbor genes
was also on the list were retained.
Ǌ.ǌ.Ǐ SĹłňĽŉĽŋĽŉŏ ĹňŉĽŁĵŉĽŃł
We carried out sensitivity estimation in the SC dataset, using simple simulations. In each
simulation cycle, we drew Ǎ genes randomly from every sample, and downscaled the observed
RD for those genes by a factor of Ǌ, to emulate heterozygous deletions. We then applied our
standard detection procedure to this “spiked” dataset, and tabulated the fraction of simulated
events that were detected by the algorithm.
Ǌ.ǌ.ǐ CŃŁŁŃłCNVň
We evaluated all genes that failed to achieve rƦ  Ƥ:ƫ using the linear ėt model from
Figure Ǌ.Ǌ.ǉB.ĉe results of that evaluation are shown in Figure Ǌ.ǌ.Ǌ. ĉe last row describes
result for gene RNFǉǍǈ that achieved the worst rƦ of ǈ.ǌǐ. ĉe histogram shown in the leě
columns demonstrates distribution of observed RD toMRD (taken as from Figure Ǌ.Ǌ.ǉB), In
case of a rare CNV (or lack of CNVs at all), one would expect a unimodal distribution centered
around that gene aﬃnity. For a common CNV, one additional peak corresponding to CN = ǉ
centered around half of that gene aﬃnity, and another peak corresponding to homozygous
deletion (CN = ǈ) around ǈ, should be visible. However, the data shown do not allow identifying
Ǎǋ
such a paĨern of either bi- or tri-modal distribution.
Additionally, the histogram of quality index calculated for that gene is presented in the right
column. ĉe low values of quality index further corroborate the conclusion that the absence of a
call in that locus is due to lack of high quality data rather than due to a hypothetical common
CNV event. Careful inspection of the graphs calculated for all ǎǑ genes the failed simple linear ėt
reveals lack of evidence for a common CNV in any of them. Notably, in the SC dataset only Ǌǐƻ
of GSS in genes with rƦ < Ƥ:ƫ were potentially detectable vs. ǎǊƻ in genes with rƦ  Ƥ:ƫ.
With no common CNV present in the experimental data, we tested the sensitivity of our
algorithm using simulated deletions. We used realistic gene aﬃnities (mean and three quartiles
from Figure Ǌ.Ǌ.ǊB) and the empirical MRDs for ǉǈǎ samples. We assumed frequency of the
deleted allele among ǉǈǎ samples varying from ǈ to ǉǈǈƻ in ǉǈƻ increments; we allowed for
random segregation, so that both homo- and heterozygous deletions were introduced. ĉen for
each sample we calculated the expected read depth as a product of MRD and aﬃnity; however in
the samples drawn for a heterozygous deletion we used halves of the nominal aﬃnities and in the
samples drawn for a homozygous deletion, we multiplied theMRD by ǈ.ǈǉ to account for reads
erroneously mapped into that region. Having an expected read depthm for each sample, we drew
a random read depth using a normal distribution,N(m;ODF
p
m), where ODF was assumed as ǐ.
In Figure Ǌ.ǌ.ǋB and Ǌ.ǌ.ǋC we show the results of analysis performed on simulated common
CNV events. Panel B shows rƦ values obtained from the simple linear ėt (as in Figure Ǌ.Ǌ.ǉB) and
panel C shows the rƦ values obtained from the tri-linear ėt (as in Figure Ǌ.ǌ.ǋC).ĉe uni-linear rƦ
values deteriorate with the increase of the deleted allele frequency. To the contrary, the tri-linear
rƦ values stay relatively high over wide range of the allele frequency. Finally, Figure Ǌ.Ǌ.ǋD
demonstrates that the sensitivity of the algorithm to the common CNVs remains relatively stable
over wide range of the deleted allele frequency (up to Ǒǈƻ).
Ǎǌ
Figure 6 
Figure 2.4.2: Analysis of genes that failed simple linear ﬁt. Each row describes a diﬀerent
gene. Left panels — distribution of the ratio of RD at the GSS sites to the sample MRD.
Right panels — distribution of the quality index for that gene. The non-multimodal distribu-
tions and the low quality-index values of these genes suggest that there are no common CNV
events on these loci.
ǍǍ
Figure 7 
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Figure 2.4.3: A. If a simple linear ﬁt fails, the gene aﬃnity is estimated for each gene as the
slope of the least-square-error tri-linear ﬁt between MRD and RD for that gene. B and C.
rƦ values of a simple linear ﬁt (B) and a tri-linear ﬁt (C) as a function of the deleted allele
frequency.
Ǎǎ
Ǌ.ǌ.Ǒ VĵŀĽĸĵŉĽŃł ĹŎńĹŇĽŁĹłŉň
All primers were designed using Primerǋ [ǑǑ, ǉǈǈ] with default seĨings to obtain a desired PCR
amplicon size between Ǌǈǈ bp and ǊǍǈ bp. All primers were checked with BLAT [ǉǈǉ] to avoid
known SNPs that could inĚuence primer hybridization. PCR products were run on an agarose gel
to make sure they gave no additional bands besides the expected amplicon.
Primer eﬃciencies were determined by calculating the standard curve of a serial dilution (ǌ
times, ǉǈ-fold) of pooled genomic DNA (Promega, Madison, WI). All experiments were
performed in triplicates on the Roche LightCycler ǌǐǈ platform with LightCycler ǌǐǈ SYBR
Green I Master (catƺ ǈǌǏǈǏǍǉǎǈǈǉ). ĉe volume of each reaction was Ǌǈ μl with ėnal primer
concentrations of ǌǈǈ nM.ĉe PCR was performed according to the following protocol: Ǎ min at
ƭƩ C, and ǌǍ cycles of Ǎs at ƭƩ C, ǉǈs at ƪƤ C, ǋǈs at ƫƦ C. To determine the copy number state
of an event locus, we used the Delta-Delta-Ct-Method (Ǌ-ΔΔCt) for each event locus compared
to a reference locus in the sample and a control pool of seven individuals (Promega, Madison,
WI), respectively. ĉis reference locus was not previously known to show any copy number
variation.
Among the calls made without neighboring information, we exhaustively validated all the calls
with posterior probability of ǈ.ǑǍ or more (ǌ coincided with known events [ǉǐ]; we
experimentally validated the remaining ǉǐ events). Additionally, we performed qPCR validations
for ǌ events randomly selected from those with posterior probability between ǈ.ǎǍ and ǈ.ǑǍ (Ǌ
coincided with known events [ǉǐ]; we experimentally validated the remaining Ǌ events).
Of the calls made with the neighboring information, we deemed Ǐ calls coincided with known
events [ǉǐ]; Ǐ out of ǉǈ remaining calls were submiĨed for qPCR validation. For the purpose of
validation, the fold change for a given gene <ǈ.Ǐ was classiėed as a positive validation, >ǈ.ǐ as a
negative validation and in the intermediate range as inconclusive.
ǍǏ
If the facts don’t ėt the theory, change the facts.
Albert Einstein
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Tangram: An inclusive toolbox forMEI detection
MŃĶĽŀĹ ĹŀĹŁĹłŉň (MEs) constitute greater than ǌǍƻ of the human genome asa result of repeated insertion events during human genome evolution. Althoughmost of these elements are now ėxed in the population, someMEs, including
ALU, Lǉ, SVA and HERV-K, are still actively duplicating. Mobile element insertions (MEIs) have
been associated with human genetic disorders, including Crohn’s disease [ǉǈǊ],
hemophilia [ǉǈǋ], and various types of cancers [ǉǈǌ, ǉǈǍ], motivating the need for accurate MEI
detection methods. To comprehensively identify and accurately characterize these variants in
whole genome next-generation sequencing (NGS) data, a computationally eﬃcient detection
and genotyping method is required. Current computational tools [ǎǌ, ǎǍ, Ǐǎ, ǉǈǎ] are unable to
Ǎǐ
call MEI polymorphisms with suﬃciently high sensitivity and speciėcity, or call individual
genotypes with suﬃciently high accuracy.
Here we report Tangram, a computationally eﬃcient MEI detector program that integrates
read-pair (RP) and split-read (SR) mapping to detect MEI events. By utilizing SRmapping in its
primary detection module, Tangram is able to pinpoint MEI breakpoints with single-nucleotide
precision. To understand the role of MEI events in disease, it is essential to produce accurate
individual genotypes in clinical samples. Tangram is able to predict sample genotypes with very
high accuracy. Using simulations and experimental datasets, we demonstrate that Tangram has
superior sensitivity, speciėcity, breakpoint resolution and genotyping accuracy, when compared
to other, recently developedMEI detection methods. Tangram serves as the primaryMEI
detection tool in the ǉǈǈǈ Genomes Project, and is implemented as a highly portable,
memory-eﬃcient, easy-to-use C/C++ computer program, built under an open-source
development model.
ǋ.ǉ IłŉŇŃĸŊķŉĽŃł
Structural variations (SVs), like single nucleotide polymorphisms (SNPs), are a ubiquitous
feature of genomic sequences and are major contributors to human genetic diversity and disease
[ǉǈǏ–ǉǈǑ]. With the advent of next-generation sequencing (NGS) technologies providing vast
throughput for individual resequencing, a number of new algorithms have been developed for
various SV types, including copy number variations (CNVs) [ǎǌ–ǎǎ, ǉǉǈ, ǉǉǉ], and large
deletion events [ǉǉǊ]. ĉese algorithms take advantage of various signals provided by NGS
mapping algorithms primarily read-depth (RD), and read-pair (RP) mapping positions.
However, the computational identiėcation of mobile element insertions (MEIs) with NGS data is
less well established because mobile elements (MEs) are highly repetitive DNA sequences that
are diﬃcult to align against a reference genome with commonly used mapping strategies. MEs
have propagated in the human genome through a copy-and-paste mechanism [ǉǉǋ–ǉǉǍ] and
undergone continuous ampliėcation in early primate evolution. ĉrough more than ǌǈ million
ǍǑ
years of accumulation, MEs account for nearly half of the human genome sequence [ǉǉǎ].
Although the current insertion/duplication rate of these elements is substantially reduced, many
genetic disorders, such as Crohn’s disease [ǉǈǊ], hemophilia [ǉǈǋ] and cancers [ǉǈǌ, ǉǈǍ], have
been reported to be associated with their continuing transposition into new genomic locations.
To address eﬀective detection of MEI events we developed anMEI detection pipeline around
our SPANNER SV discovery tool [ǉǉǏ], and deployed it on the Pilot data of the ǉǈǈǈ Genomes
Project (ǉǈǈǈGP) [ǉǍ]. Using this pipeline we compiled the most comprehensive catalog of MEI
events in the human genome to date [ǉǉǐ]. Although an eﬀective SV detector used extensively in
the ǉǈǈǈGP [ǎǋ], SPANNER only uses RP signal, limiting the precision of breakpoint prediction,
detection sensitivity as well as the genotype accuracy that can be achieved.
More recently, three NGS-basedMEI detectors, RetroSeq [ǉǉǑ], TEA [ǉǈǍ] and
VariationHunter [ǉǊǈ], have been published, each with speciėc limitations. For example, TEA
and VariationHunter do not provide sample genotypes, limiting their use for single-sample
detection pipelines e.g. in personal genome sequencing projects; or genotype data likelihoods
that are essential for phasing structural variants together with SNPs and short INDELs. Also,
none of these detectors eﬃciently integrate the SR and RP signals: VariationHunter detects MEIs
using RP signal alone; RetroSeq and TEA only trigger SR analysis when RP signal suggests a
potential MEI, and therefore misses events for which only SR evidence is available from the reads
(See Table ǋ.Ǌ.ǉ). Because of the steady increase in the read lengths generated by today’s
sequencing technologies, SR methods are becoming more powerful because these longer reads
support conėdent mapping across SV event breakpoints. ĉerefore, it is reasonable to expect that
using both SR signal and RP signal on an equal footing, as primary observations for “nucleating”
SV event calls, will be more sensitive than RP signal alone, or RP signal in combination with a
secondary SR search. As a more practical point, the TEA and VariationHunter programs produce
reports in non-standard formats, rather than the well established standard VCF format [ǉǊǉ], an
issue for data communication and downstream analysis. Finally, all the above tools focus on the
detection of NON-LTR events, such as ALUs, Lǉs and SVA, and they do not address the
ǎǈ
detection of LTRs, such as HERV-K, in the human genome.
ǋ.Ǌ RĹňŊŀŉň
Here we report a fast and convenient MEI detection toolbox, Tangram, which eﬀectively
integrates signals provided by both RP and SRmapping. What sets our approach apart from
existing methods is the “global” use of SRmapping: we perform a SRmapping step for all
orphaned or substantially soě-clipped reads before the detection begins, and therefore both RP
and SRmappings are available at the outset, and can nucleate SV event calls. We target both
NON-LTR and LTRmobile element types. ĉe global use of SRmapping substantially improves
the accuracy of identifying SV event boundaries (breakpoints). Our method produces sample
genotypes as well as genotype likelihoods. Unlike other SV detection tools, Tangram is able to
detect MEIs for a single individual genome and simultaneously process multiple sequence
alignment (BAM) [ǉǊǊ] ėles to call MEI events on population-scale data, and can deal with
multiple fragment length libraries and a mixture of read lengths within a single detection step.
Tangram is memory and CPU eﬃcient, as analysis is carried out locally i.e. event detection in any
given region only requires reading the alignment within that region. To our knowledge, there are
currently no other detectors that can provide such a comprehensive set of features required for
the full characterization of MEIs within a single sample, or a large collection of samples.
ǋ.Ǌ.ǉ PĹŇĺŃŇŁĵłķĹ ĹŋĵŀŊĵŉĽŃł Ńł ňĽŁŊŀĵŉĹĸ ĸĵŉĵňĹŉň
We evaluated the detection and genotyping performance of Tangram with a series of in silico
experiments involving the insertion of ǉ,ǈǈǈ full-length AluY elements into the sequence of
human chromosome Ǌǈ (to closely reĚect the real insertion, each inserted AluY element was
aĨached with ǉǍ bp poly-A tails and ǉǍ bp target-site duplication sequence), and generating
simulated paired-end sequencing reads of various lengths with realistic base error properties (See
Methods ǋ.ǌ.Ǐ). Aěer aligning these reads to the human reference genome sequence using our
MOSAIK read mapping program [ǍǏ], we applied Tangram detect MEI events and to generate
ǎǉ
sample genotype calls (see Table ǋ.Ǌ.ǉ and ǋ.Ǌ.Ǌ). For comparison, we also ran the RetroSeq
program on the same dataset (aligned with the BWAmapping program [Ǎǐ], using default
parameters, as instructed by the RetroSeq paper [ǉǉǑ]), and compared detection sensitivity and
genotyping accuracy, for various read lengths and levels of sequence coverage, considering both
heterozygous and homozygous events i.e. case where theMEI event is present in one or both
chromosome copies within the cell. TEA and VariationHunter do not report sample genotypes,
and therefore we did not use these two programs in the comparisons.
As Table ǋ.Ǌ.ǉ shows, Tangram’s sensitivity exceeds ǑǏƻ both for heterozygous and
homozygous events in ǉǈ sequence coverage or greater. Even in low-coverage sequence (Ǎ is
the approximate average sequence coverage in the low-coverage ǉǈǈǈGP datasets), Tangram
maintains >ǐǈƻ sensitivity. Tangram’s sensitivity substantially exceeds that of the RetroSeq
program, especially when detecting heterozygous events in low-coverage (Ǎ) data.
We also tabulated genotype calling accuracy i.e. the rate at which a given algorithm provides
the correct genotype for a given simulated sample (i.e. noMEI, heterozygousMEI, homozygous
MEI). As Table ǋ.Ǌ.Ǌ indicates, Tangram is able to call sample genotypes with >Ǒǈƻ accuracy for
all coverage levels and event ploidy we considered. Accuracy in our simulated data is nearly
perfect for heterozygous events over ǉǈ coverage, and for homozygous events over Ǌǈ
coverage. ĉese accuracy values compare very favorably with those obtained for RetroSeq, which
appears to heavily favor homozygous calls in low-coverage data, and heterozygous calls in deeper
sequence coverage, and has a very high error rate in the non-favored category. ĉe overall
accuracy of the Tangram genotypes, obtained by a judicious mixing of heterozygous and
homozygous events, is high, over Ǒǎƻ, in every category, again, substantially higher than what was
obtained with RetroSeq.
Determining the exact location of SV event boundaries is notoriously diﬃcult. In the
simulation experiments performed here, Tangram was able to assignMEI breakpoints at or near
single nucleotide resolution using the SR signal. For ǉǈǎ bp reads, greater than ǎǍƻ of the
ǎǊ
Table 3.2.1: Results are shown for the Tangram and RetroSeq programs applied to simulated
data (1,000 ALUY insertions introduced at random positions on human chromosome
20).Simulated reads were generated under: diﬀerent ploidy values (homozygous or
heterozygous), read length (76bp and 106bp) and read coverage (5, 10, 20). The two
columns “Sen (RP\SR)” and “Sen (SR\RP)” indicate the sensitivity of the RP and SR
methods respectively, when considered in isolation. The best result in each row is indicated in
boldface text.(Pldy: Ploidy, RL: Read Length, Cov: Coverage)
Parameters Tangram RetroSeq
Pldy RL Cov Sen(RP) Sen(SR) Sen(RP\SR) Sen(SR\RP) Sen Sen
Het
Ǐǎbp
Ǎ ǎǏ.ǎƻ ǎǈ.ǈƻ ǊǍ.ǌƻ ǉǏ.ǐƻ ǐǍ.ǌƻ ǌǋ.Ǐƻ
ǉǈ ǐǋ.ǌƻ ǐǐ.Ǒƻ ǐ.ǐƻ ǉǌ.ǋƻ ǑǏ.Ǐƻ Ǒǋ.ǎƻ
Ǌǈ ǐǌ.Ǌƻ ǑǏ.ǐƻ ǉ.Ǌƻ ǉǌ.ǐƻ ǑǑ.ǈƻ Ǒǐ.Ǒƻ
ǉǈǎbp
Ǎ ǌǍ.ǉƻ ǎǏ.ǋƻ ǉǋ.Ǒƻ ǋǎ.ǉƻ ǐǉ.Ǌƻ ǉǊ.ǈƻ
ǉǈ ǏǏ.ǈƻ Ǒǋ.ǈƻ ǌ.Ǎƻ Ǌǈ.Ǎƻ ǑǏ.Ǎƻ ǎǐ.Ǒƻ
Ǌǈ ǐǋ.ǌƻ Ǒǐ.Ǒƻ ǈ.ǌƻ ǉǍ.Ǒƻ ǑǑ.ǋƻ ǑǏ.Ǐƻ
Homo
Ǐǎbp
Ǎ ǐǋ.ǌƻ ǐǐ.Ǒƻ ǐ.ǐƻ ǉǌ.ǋƻ ǑǏ.Ǐƻ ǑǍ.Ǌƻ
ǉǈ ǐǌ.Ǌƻ ǑǏ.ǐƻ ǉ.Ǌƻ ǉǌ.ǐƻ ǑǑ.ǈƻ Ǒǐ.ǐƻ
Ǌǈ ǐǌ.ǎƻ ǑǑ.ǉƻ ǈ.ǌƻ ǉǌ.Ǒƻ ǑǑ.Ǎƻ ǑǑ.Ǌƻ
ǉǈǎbp
Ǎ ǏǏ.ǈƻ Ǒǋ.ǈƻ ǌ.Ǎƻ Ǌǈ.Ǎƻ ǑǏ.Ǎƻ ǎǐ.Ǒƻ
ǉǈ ǐǋ.ǌƻ Ǒǐ.Ǒƻ ǈ.ǌƻ ǉǍ.Ǒƻ ǑǑ.ǋƻ ǑǏ.Ǐƻ
Ǌǈ ǐǋ.ǐƻ ǑǑ.ǋƻ ǈ.ǌƻ ǉǍ.Ǒƻ ǑǑ.Ǐƻ Ǒǐ.Ǒƻ
ǎǋ
Table 3.2.2: For each simulated dataset corresponding to a speciﬁc read length and coverage,
we randomly chose 500 MEI loci. 400 were designated as heterozygous sites, and 100 as
homozygous sites. The genotype accuracy was then calculated for these loci. The random
selection and genotype accuracy experiment was then repeated ﬁve times (to give a sample of
2,500 MEI loci) and the overall genotype accuracy was determined by averaging the results of
the ﬁve experiments. The best result in each row is indicated in boldface text. (RL: Read
Length, Cov: Coverage)
Parameters Tangram RetroSeq
RL Cov Het Homo Total Het Homo Total
Ǐǎbp
Ǎ ǑǑ.ǋƻ Ǒǈ.ǐƻ ǑǏ.ǎƻ Ǌ.ǋƻ ǑǊ.ǐƻ Ǌǈ.ǌƻ
ǉǈ ǉǈǈ.ǈƻ Ǒǌ.Ǌƻ Ǒǐ.ǐƻ ǌǈ.ǎƻ ǎǋ.ǎƻ ǌǍ.Ǌƻ
Ǌǈ ǉǈǈ.ǈƻ Ǒǐ.ǌƻ ǑǑ.Ǐƻ Ǒǎ.Ǎƻ ǐ.ǐƻ Ǐǐ.Ǒƻ
ǉǈǎbp
Ǎ Ǒǎ.ǎƻ Ǒǋ.ǌƻ Ǒǎ.ǈƻ ǈ.ǈƻ Ǒǉ.ǎƻ ǉǐ.ǋƻ
ǉǈ ǑǑ.ǎƻ ǑǊ.ǎƻ Ǒǐ.Ǌƻ ǋǐ.ǐƻ ǎǌ.ǌƻ ǌǋ.Ǒƻ
Ǌǈ ǉǈǈ.ǈƻ ǑǍ.ǎƻ ǑǑ.ǉƻ ǑǍ.ǉƻ ǉǈ.ǐƻ ǉǑ.ǎƻ
reported breakpoints co-locate exactly with, and over ǑǑƻ are within ǉǍ bp of the true
breakpoints (see Figure ǋ.Ǌ.ǉ). ĉis performance is aĨributable to SR-mapped reads identifying
the breakpoints at a resolution that RP-only methods are unable to match.
ǋ.Ǌ.Ǌ PĹŇĺŃŇŁĵłķĹ ķŃŁńĵŇĽňŃłň ŊňĽłĻ ǉǈǈǈ GĹłŃŁĹň PŇŃľĹķŉ ĸĵŉĵ
We ran Tangram and two other MEI detection algorithms, RetroSeq and TEA, to analyze
deep-coverage sequencing data from a CEU trio consisting of samples NAǉǊǐǏǐ (Ƭƭ),
NAǉǊǐǑǉ (ƫƬ) and NAǉǊǐǑǊ (ƫƬ), obtained from the public ǉǈǈǈGP ěp site. ĉe DNA of
these individuals were collected from fresh blood cells. All people who contributed their DNA to
this project are anonymous and have no phenotype data available. Trio data were sampled from
mother-father-adult child families. ĉe detailed data collection guideline can be found from the
supplemental information of [ǉǊǋ]. ĉe data consists of ǉǈǉ bp paired-end reads generated by
Illumina HiSeq sequencing machines; insert size was ǌǎǍ ± Ǎǈ bp (median ± standard deviation).
Wemapped the reads withMOSAIK Ǌ.ǈ [ǍǏ] for Tangram and BWA [Ǎǐ] for RetroSeq and TEA,
ǎǌ
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Figure 3.2.1: Breakpoint resolution of Tangram and Retroseq. The diﬀerence between re-
ported and true breakpoint position in simulated data is shown for the Tangram and the Ret-
roSeq MEI detection algorithms (homozygous events in 76 bp paired-end reads, 20 sequence
coverage). The majority of breakpoints reported by Tangram exactly match the true break-
point.
ǎǍ
according to author instructions. To assess sensitivity and genotype accuracy, we compared the
MEI loci (ALU and Lǉ) reported by the three detectors to the events reported and
experimentally characterized in a previous large-scale study [ǉǉǐ] using an earlier set of ǉǈǈǈGP
data for the same samples (characteristics of this dataset from the ǉǈǈǈGP Pilot Ǌ trio data are
reported in Table ǋ.Ǌ.ǋ). ĉe Stewart et al. Ǌǈǉǉ [ǉǉǐ] callset consisted of ǉ,Ǌǈǐ Alu and ǉǐǈ Lǉ
Table 3.2.3: Sequence coverage (base coverage) for two sequencing technologies (454 and
Illumina) of CEU trio (NA12878, NA12891 and NA12892) used in 1000GP Pilot MEI
paper [118].
Samples ǌǍǌ Illumina
NAǉǊǐǏǐ ǉǉ.ǈ ǉǍ.Ǒ
NAǉǊǐǑǉ ǈ.ǈ ǉǌ.Ǒ
NAǉǊǐǑǊ ǈ.ǈ Ǒ.Ǌ
calls, including ǌǐǎ Alu and ǌǐ Lǉ insertions that were experimentally conėrmed with a
PCR-based validation technique. As shown in Table ǋ.Ǌ.ǌ, Tangram recovered >Ǒǐƻ of PCR
validated events and > Ǒǋƻ of all reported events. RetroSeq provided comparable results, but
TEA was unable to achieve this level of sensitivity to ALU events. Tangram’s genotype accuracy
for ALU events was > Ǒǉƻ for all three samples. Tangram detected approximately ǐǏƻ of PCR
validated Lǉ insertion events, outperforming the two competing algorithms. Tangram’s
sensitivity to Lǉ events reported in the Stewart et al. Ǌǈǉǉ data set drops markedly in comparison
to the PCR-validated events. ĉis is likely the result of the high false discovery rate (FDR) for Lǉ
events (ǉǐ.ǐƻ) in the Stewart et al. Ǌǈǉǉ data set. Notably, our algorithms called none of the
events reported in the Stewart et al. Ǌǈǉǉ dataset that failed PCR validation. It is notable that
sample NAǉǊǐǏǐ had the highest number of MEI calls using either of the calling methods. ĉis is
likely the result of the substantially higher read coverage in this sample, as well as longer reads
from ǌǍǌ sequencing machines, not available for the other two samples (Table ǋ.Ǌ.ǋ).
Our experiments here demonstrate that Tangram provides accurate MEI genotypes across all
MEI types (see Table ǋ.Ǌ.Ǎ). ĉe TEA program does not provide sample genotypes, and
ǎǎ
Table 3.2.4: Comparisons are shown for a CEU trio (NA12878, NA12891 and NA12892)
processed with Tangram, RetroSeq and TEA.Sensitivity and genotype accuracy was measured
by comparing the reported events with those in Stewart et al., 2011 [118]. The total number
of validated and reported MEI loci are shown under the “Stewart et al. 2011” column. The
two sub columns under each detector, “Validated” and “Reported”, show the sensitivity to
PCR validated loci and all reported loci in Stewart et al. 2011, respectively. The TEA program
does not provide genotype calls, and therefore could not be used for genotype accuracy
comparisons. The best result in each row is indicated in boldface text.
Stewart et al. Ǌǈǉǉ Tangram RetroSeq TEA
Sample Loci Sensitivity Genotype Sensitivity Genotype Sensitivity
Validated Reported Validated Reported Validated Reported Validated Reported
ALU
NAǉǊǐǏǐ ǌǈǐ ǑǎǍ Ǒǐ.ǐƻ Ǒǋ.ǈƻ ǑǍ.ǈƻ Ǒǌ.ǉǈƻ ǐǏ.Ǐǈƻ Ǐǎ.ǌǈƻ ǐǑ.Ǎǈƻ ǐǊ.Ǌǈƻ
NAǉǊǐǑǉ ǋǈǑ ǎǏǍ Ǒǐ.ǉƻ Ǒǎ.ǋƻ Ǒǉ.Ǌƻ Ǒǐ.ǌǈƻ Ǒǎ.ǌǈƻ ǎǏ.Ǒǈƻ Ǒǎ.ǉǈƻ Ǒǋ.ǐǈƻ
NAǉǊǐǑǊ ǋǉǊ ǎǍǈ Ǒǐ.ǉƻ Ǒǎ.Ǒƻ ǑǊ.ǎƻ ǑǑ.ǈǈƻ ǑǏ.ǌǈƻ Ǐǉ.Ǌǈƻ Ǒǌ.Ǌǈƻ ǑǊ.Ǎǈƻ
Lǉ
NAǉǊǐǏǐ ǋǐ ǉǍǏ ǐǎ.ǐƻ ǍǊ.Ǌƻ ǐǏ.Ǎƻ Ǐǐ.Ǒǈƻ ǌǍ.ǐǈƻ ǐǋ.ǋǈƻ ǐǌ.Ǌǈƻ ǌǑ.Ǐǈƻ
NAǉǊǐǑǉ Ǌǎ ǎǌ ǑǊ.ǋƻ ǏǍ.ǈƻ ǉǈǈ.ǈƻ Ǐǎ.Ǒǈƻ ǎǌ.ǉǈƻ ǎǎ.Ǐǈƻ ǐǌ.ǎǈƻ Ǐǈ.ǋǈƻ
NAǉǊǐǑǊ ǋǌ Ǐǎ Ǒǌ.ǉƻ Ǐǎ.ǋƻ ǐǍ.Ǐƻ ǏǑ.ǌǈƻ ǎǍ.ǐǈƻ Ǎǈ.ǈǈƻ Ǐǎ.Ǎǈƻ ǎǌ.Ǎǈƻ
therefore we were not able to include it in this comparison. RetroSeq appears to suﬀer from a
systematic bias when applied to deep-coverage data: it called almost all MEI loci as heterozygous.
In comparison, Tangram can eﬀectively distinguish between homozygous and heterozygous loci.
ǋ.Ǌ.ǋ RŊłłĽłĻ TĵłĻŇĵŁ Ńł ńŃńŊŀĵŉĽŃł ĸĵŉĵ
We deployed Tangram on Ǌǉǐ samples from the ǉǈǈǈGP Phase ǉ release [ǉǊǋ]. ĉree
populations were included in this dataset: ASW (people with African ancestry in Southwest
United States, Ǎǈ individuals), LWK (Luhya inWebuye, Kenya, ǐǋ individuals) and YRI (Yoruba
in Ibadan, Nigeria, ǐǍ individuals). ĉese data were collected with same strategy as the
deep-coverage trio data mentioned above. However, the sequencing coverage for these samples is
much lower. On average, each sample had Ǎ sequence coverage so the overall coverage of this
dataset is ~ǉ,ǈǈǈ. ĉe allele frequency spectrum (AFS) of all MEIs for each of the three
populations (ǌ,ǈǐǍ ALU, ǉ,Ǎǌǐ Lǉ, ǐǐ SVA and ǌǌ HERV-K insertions) is shown in Figure ǋ.Ǌ.Ǌ.
ĉe expectation is that the AFS of MEIs is similar to AFS observed from SNP data [ǉǉǐ]. ĉis is
indeed the case, except at very low allele frequency, where detection sensitivity drops oﬀ in the
low-coverage ǉǈǈǈGP datasets (as there may be too few RP and/or SRmapped reads supporting
ǎǏ
Table 3.2.5: A contingency table is shown for MEI genotypes reported by Tangram and
RetroSeq on deep coverage sequencing data from a CEU trio (NA12878, NA12891 and
NA12892).The “Genotype from validation” column shows the genotype that was validated in
Stewart et al. 2011 [118]. The “Genotype call” column shows the genotype predicted by
Tangram and RetroSeq at the same loci. The “Genotype” column in Table 3.2.4 was
calculated based on the results in this table.
Tangram RetroSeq
Genotype from Genotype call Genotype call
validation Het Homo Het Homo
ALU
NAǉǊǐǏǐ Het ǉǊǈ ǐ ǉǉǑ ǈ
Homo ǉ Ǌǎ ǋǏ ǉ
NAǉǊǐǑǉ Het ǑǍ ǉǋ Ǒǋ ǈ
Homo ǈ ǌǈ ǌǌ ǈ
NAǉǊǐǑǊ Het ǉǈǎ ǉǉ ǉǈǌ ǈ
Homo ǈ ǋǊ ǌǊ ǈ
Lǉ
NAǉǊǐǏǐ Het Ǎ ǉ ǌ ǈ
Homo ǈ Ǌ ǉ ǉ
NAǉǊǐǑǉ Het ǌ ǈ Ǌ ǈ
Homo ǈ Ǌ ǉ ǈ
NAǉǊǐǑǊ Het ǋ ǉ ǋ ǈ
Homo ǈ ǋ ǋ ǈ
ǎǐ
Table 3.2.6: Genomic distribution of MEI events detected from the AFR dataset.
Genomic Region Number ofMEIs
Intergenic ǋ,ǊǌǑ
Intron Ǌ,ǌǋǑ
ǋ’ UTR Ǎǌ
Ǎ’ UTR Ǌǋ
Exon ǈ
a MEI event). ĉe genomic distribution of these Ǎ,ǏǎǍMEI events is shown in Table ǋ.Ǌ.ǎ. Most
of the detectedMEI events (Ǒǐ.Ǐƻ) fall into the intergenic and intronic regions whereas none of
the events are found in the exon regions. ĉis observation is very similar to the results from
Stewart et al. Ǌǈǉǉ [ǉǉǐ]. ĉe absence of MEI events in exonic regions could be aĨributed to the
selection pressure since such long insertion events could substantially interrupt the transcription
process (See Discussion ǌ.ǉ.ǋ).
ǋ.Ǌ.ǌ EŎńĹŇĽŁĹłŉĵŀ ŋĵŀĽĸĵŉĽŃł
To assess the speciėcity of Tangram, researchers (Dr. Miriam Konkel and Dr. Mark Batzer) from
Louisiana State University helped us perform the PCR validation experiment on Ǌǋ ǉǈǈǈGP
Phase ǉ [ǉǊǋ] samples (Table ǋ.Ǌ.Ǐ), including a CEU trio (NAǉǊǐǏǐ, NAǉǊǐǑǉ and NAǉǊǐǑǊ)
with deep coverage (~Ǌǈ) and Ǌǈ low-coverage (~Ǎ) samples from the CHS and LWK
populations. Tangram detected Ǌ,ǐǏǌ ALU, ǊǍǎ Lǉ, Ǎǋ SVA and ǊǊ HERV-K insertions in these
samples. Of the ǋ,ǊǈǍ loci, ǋǍǏ were novel, i.e. not reported in previous studies [ǉǉǐ, ǉǊǌ–ǉǋǈ],
and absent from the dbRIP database [ǉǋǉ]. Two random subsets, ǉǎǈ sites in all, were randomly
selected for PCR validation: (ǉ) ǐǈ loci (ǎǎ known + ǉǌ novel) were randomly selected from the
entire callset of ǋ,ǊǈǍMEIs; and (Ǌ) additional ǐǈ loci were randomly selected only from the
novel ǋǍǏ novel calls. PCR validation results for Tangram and VariationHunter are shown in
Table ǋ.Ǌ.ǐ and Table ǋ.Ǌ.Ǒ. Tangram achieved very low FDR for all three non-LTRMEI types
(<ǎƻ). Although the numbers are low, no false positive Lǉ and SVA calls were reported. ĉe
ǎǑ
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Figure 3.2.2: Allele frequency spectrum for MEI variants detected in 3 African populations.
Results for samples designated as ASW, LWK and YRI are shown, for 4 types of MEIs: ALU,
L1, SVA and HERV-K. There is limited sensitivity to low frequency events because of sparse
or absent supporting reads in low-coverage data.
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Figure 3.2.3: Motifs reported by MEME software [132] by using sequences (±25bp) around
the ALU and L1 breakpoints detected by Tangram in 23 1000 Genome Project Phase 1 sam-
ples. They are highly consistent with the canonical ALU and L1 recognition motifs.
overall estimated FDR for the ėrst and second validation sets were Ǌ.Ǎǋƻ and Ǒ.Ǌǉƻ, respectively.
ĉis result is consistent with expectations that newly detected, previously unknown events have
higher FDR. In Table ǋ.Ǌ.Ǒ, we compared experimental validation results for three algorithms:
Tangram, RetroSeq, and VariationHunter, for event types detected by each calling algorithm.
Tangram achieves substantially higher speciėcity than the two competing algorithms. In fact, this
level of accuracy is comparable to or beĨer than the FDR of SNP calls from current
state-of-the-art variant callers [ǉǊǋ].
Consistently with the validation results, a copy of the canonical ALU and Lǉ recognition motif,
5'-TTAAAAA-3', was found within a ǊǍ bp window of all reported breakpoints (Figure ǋ.Ǌ.ǋ),
further conėrming the high speciėcity of our detection method.
Ǐǉ
Table 3.2.7: Samples and sequence coverage of CEU trio and 20 1000GP phase I samples
used for PCR validation
Sample Population Platform
NAǉǑǋǑǏ LWK ILLUMINA
NAǉǑǋǑǐ LWK ILLUMINA
NAǉǑǋǑǑ LWK ILLUMINA
NAǉǑǌǈǌ LWK ILLUMINA
NAǉǑǌǊǐ LWK ILLUMINA
NAǉǑǌǊǑ LWK ILLUMINA
NAǉǑǌǋǌ LWK ILLUMINA
NAǉǑǌǋǍ LWK ILLUMINA
NAǉǑǌǌǈ LWK ILLUMINA
NAǉǑǌǌǋ LWK ILLUMINA
HGǈǈǎǎǊ CHS ILLUMINAHiSEQ
HGǈǈǎǎǋ CHS ILLUMINAHiSEQ
HGǈǈǎǏǉ CHS ILLUMINAHiSEQ
HGǈǈǎǏǊ CHS ILLUMINAHiSEQ
HGǈǈǎǐǋ CHS ILLUMINAHiSEQ
HGǈǈǎǐǌ CHS ILLUMINAHiSEQ
HGǈǈǎǐǑ CHS ILLUMINAHiSEQ
HGǈǈǎǑǈ CHS ILLUMINAHiSEQ
HGǈǈǌǎǌ CHS ILLUMINAHiSEQ
HGǈǈǎǉǌ CHS ILLUMINAHiSEQ
NAǉǊǐǏǐ CEU Multiple
NAǉǊǐǑǊ CEU Multiple
NAǉǊǐǑǉ CEU Multiple
ǏǊ
Table 3.2.8: PCR validation results for the Tangram MEI detector. Validation results and
estimated false discovery rates are shown for MEI calls from 23 1000 Genomes Project Phase 1
samples.
ALU Lǉ SVA HERV-K Total
Random Novel Random Novel Random Novel Random Novel Random Novel
Analyzed by PCR ǎǐ ǎǌ Ǐ ǋ ǋ ǎ ǉ ǋ ǐǈ Ǐǐ
Validated Loci ǎǎ Ǎǐ Ǐ ǋ ǋ ǎ ǉ Ǌ ǏǏ ǎǑ
Invalidated Loci Ǌ ǎ ǈ ǈ ǈ ǈ ǈ ǉ Ǌ Ǐ
FDR Ǌ.Ǒǌƻ Ǒ.ǋǐƻ ǈ.ǈǈƻ ǈ.ǈǈƻ ǈ.ǈǈƻ ǈ.ǈǈƻ ǈ.ǈǈƻ ǋǋ.ǋǋƻ Ǌ.Ǎǋƻ Ǒ.Ǌǉƻ
Table 3.2.9: Comparison of PCR validation results across three MEI detection algorithms.
Calls were made in 23 1000 Genomes Project Phase 1 samples by Tangram, RetroSeq and
VariationHunter.The best result is indicated in boldface text.
Tangram RetroSeq VariationHunter
Random Novel Combined Random Novel Combined Random Novel Combined
Analyzed by PCR ǐǈ Ǐǐ ǉǍǐ ǐǈ ǐǈ ǉǍǑ ǐǋ Ǎǉ ǉǋǌ
Validated Loci ǏǏ ǎǑ ǉǌǊ Ǐǋ Ǎǐ ǉǋǉ ǎǑ ǊǑ Ǒǐ
Invalidated Loci Ǌ Ǐ Ǒ Ǐ Ǌǉ Ǌǐ ǉǌ ǊǊ ǋǎ
FDR Ǌ.Ǎǋƻ Ǒ.Ǌǉƻ Ǎ.Ǒǎƻ ǐ.ǏǍƻ Ǌǎ.Ǎǐƻ ǉǏ.ǎǉƻ ǉǎ.ǐǏƻ ǌǋ.ǉǌƻ Ǌǎ.ǐǎƻ
Ǐǋ
ǋ.Ǌ.Ǎ RĹňŃŊŇķĹ ŇĹŅŊĽŇĹŁĹłŉň ĵłĸ ňŃĺŉŌĵŇĹ ĵŋĵĽŀĵĶĽŀĽŉŏ
ĉe primary motivation behind developing Tangramwas to provide highly accurateMEI calls. To
be a useful soěware tool, however, it must be easy to install, easy to run, and generate results in a
timely fashion, using reasonable computational resources. We characterized resource usage and
analysis time on our analysis of the Ǌǉǐ ǉǈǈǈGP low-coverage samples described [ǉǊǋ]. When
using other MEI detection soěware, it is a common requirement that only a single BAM ėle can
be processed at a time, necessitating all input BAM ėles to be merged into a single ėle (a lengthy
task), or to process each BAM ėle individually (reducing sensitivity to low-frequency events).
Tangram, in contrast, can process all input BAM ėles simultaneously. Most currently available
structural variant callers employ multiple passes through the entire input ėle, requiring
substantial memory and computation time. To reduce the memory footprint and increase the
throughput, Tangram was designed to call MEI events regionally, i.e. within shorter windows of
the sequence alignment. Single-pass analysis is made possible by annotation tags produced by our
MOSAIK read mapper soěware [ǍǏ], marking reads whose fragment-end paired mate maps into
ME reference sequence. Additional parallelization was accomplished by multi-threaded
implementation of the soěware. In this test, we submiĨed one Tangram detection job for each
chromosome (Chrǉ-ChrX). Each job used one AMDOpteron ǎǉǋǌ CPU (ǐ cores at Ǌ.ǋGHz).
ĉe detection process ėnished within Ǎǐ hours (wall time) or Ǒǎ hours (CPU time). Repeating
the detection process in ǉMbp detection windows on the same cluster resource requires ǈ.Ǌǌ
hours (wall time) or ǈ.ǌǈ hours (CPU time).
Tangram is easy to install and run. Users can download it from its main github repository
(hĨps://github.com/jiantao/Tangram). We have also integrated it into our pipeline and tool
launcher system, GKNO, available at hĨp://gkno.me.
Ǐǌ
ǋ.ǋ DĽňķŊňňĽŃł
ManyMEI events have strong impact on gene function and they are therefore essential to
accurately detect and genotype within individuals. Mobile elements are, by nature, repetitive
sequences and are therefore diﬃcult to detect. To our knowledge, our Tangram soěware is the
only robust soěware capable of detecting all classes of MEIs, providing accurate individual
genotype information, and accurate, near base-perfect breakpoint localization. We believe that
Tangram can achieve higher sensitivity, speciėcity, genotyping accuracy, and breakpoint calling
accuracy than competingMEI detection methods because of the global use of split-read mapping
information into the detection process. Competing algorithms either only use RPmapping
information to call events, or perform SRmapping in regions where RPmappings indicate a
possible MEI events. In contrast, Tangram analyses both RP and SRmapped reads from the start,
and can therefore detect events for which only SRmapping evidence exists.
Table ǋ.Ǌ.ǉ illustrates detection sensitivity when RP or SR signal is used in isolation, or in
combination with each other. At almost all read length and coverage values, the SRmethod on its
own is more sensitive that the RPmethod (except for low, Ǎ coverage in Ǐǎ bp reads).
Importantly, RP detection sensitivity does not exceed ǐǍƻ, even in deep-coverage data. ĉis is
because RP-mapped reads localize theME insertion point to a window. If the reference sequence
already contains a ME within this window, one must ėlter out the candidate event because of the
high likelihood of spurious detection. SRmapping localizes the insertion site with much greater
resolution, making it possible to distinguish betweenME elements in the reference, and
polymorphic insertions not present in the reference.
Table ǋ.Ǌ.ǉ also illustrates that RP based methods that use a secondary SRmapping step can
perform very well in deep sequencing data because in such high-coverage datasets there are likely
read pairs mapping across the breakpoints, and then additional reads that can be SR-mapped
across the breakpoint for ėne localization. In low-coverage data however, there are many events
without read pairs mapping across the breakpoints. When using shorter reads, reliable SR
ǏǍ
mapping becomes diﬃcult. In both cases, sensitivity suﬀers. As through technology development
read lengths increase, the same sequence coverage will be accomplished with fewer, but longer,
reads. Moving forward, this trend clearly favors SRmapping methods, and in particular, methods
that use SRmapping as part of their primary detection approach. As we demonstrate in this study,
such methods are more sensitive and speciėc, have higher genotype accuracy, and are able to
localize event boundaries more accurately.
OurMEI detector program, Tangram is a fast, accurate tool that has been extensively tested
and benchmarked in the analysis of the ǉǈǈǈGP sequencing datasets. It is easy to install, easy to
use, and is available as a stand-alone package or as part of our tool and pipeline launching system,
making it especially useful for medical or population sequencing projects.
ǋ.ǌ MĹŉļŃĸň
ǋ.ǌ.ǉ TļĹ TĵłĻŇĵŁ ĸĹŉĹķŉŃŇ—ĵŀĻŃŇĽŉļŁĽķ ŃŋĹŇŋĽĹŌ
As input, Tangram uses reads aligned to the genome reference sequence as well as to mobile
element reference sequences, available in BAM format alignment ėle(s). Currently, alignments to
ME reference sequences can be produced by theMOSAIKmapping soěware (version Ǌ.ǈ or
above) [ǍǏ]. Tangram’s RP detection module ėrst scans the alignment for read pairs where one
mate uniquely aligns to the genome reference, and the other mate maps to aME reference
sequence (Figure ǋ.ǌ.ǉA). Second, read pairs where one mate is aligned to the genome reference
uniquely (i.e. with high read mapping quality value, or MQ), but the other mate either
soě-clipped or entirely unaligned, are collected as the starting material for SRmapping
(Figure ǋ.ǌ.ǉB).ĉe SRmodule aĨempts to align these soě-clipped or unaligned mates both the
genome reference and to theME reference sequences in a split fashion (i.e. aligning one section of
the read to the genome reference and another section to theME reference). Loci in the genome
with either RP or SR evidence for a candidate MEI event are then extracted. Candidate events are
ėltered on the number and type of supporting fragments. A genotyping module produces
Ǐǎ
Figure 3.4.1: Illustration of MEI detection algorithms in Tangram. A. MEI detection with
RP signal: RP algorithm will cluster those read pairs with one mate uniquely aligned to the
normal reference (5’ – blue and 3’ – red) and the other mate aligned to the MEI special ref-
erences (green). B. MEI detection with SR signal: SR algorithm will search for unaligned or
soft-clipped reads (crossing the breakpoint from 5’ – blue or 3’ – red) and align these reads to
both the normal reference and the special MEI reference (green) after splitting them into two
subsections. Reprinted from [118] with permission.
individual genotype likelihoods and calls sample genotypes. A reporting module produces a VCF
format variant report including the location and type of the events, as well as individual sample
genotype information.
ǋ.ǌ.Ǌ SĹŅŊĹłķĹ ĵŀĽĻłŁĹłŉ ŉŃ ĻĹłŃŁĹ ĵłĸ ŁŃĶĽŀĹ ĹŀĹŁĹłŉ ŇĹĺĹŇĹłķĹ
Alignments were created with theMOSAIK program, a hash-based read mapper that is aware of
user-speciėed insertion sequences, e.g. MEIs. When the insertion sequences are provided, the
reference hashes are prioritized such that alignment to theMEI sequences are aĨempted prior to
alignment to the genome reference. SinceMEIs are repetitive elements, a read from anMEI can
be mapped to several locations within the genome (potentially hundreds of locations). An
additional tag in the BAM ėle (the ZA tag) is then populated with information about the reads
mate, including location, mapping quality and number of mapping locations for the mate. ĉis
information ensures that BAM search operations (which can be lengthy for large alignment ėles)
can be avoided.
ǏǏ
ǋ.ǌ.ǋ MEI ĸĹŉĹķŉĽŃł ĶĵňĹĸ Ńł ŇĹĵĸ-ńĵĽŇ ŁĵńńĽłĻ ńŃňĽŉĽŃłň
Tangram ėrst establishes the fragment length distribution for each library in the input BAM ėles
using “normal” read pairs (i.e. those read pairs where both mates are uniquely aligned to the same
chromosome with expected orientation). Tangram then searches the BAM ėles for
MEI-candidate read pairs that have one mate uniquely aligned to the reference genome and the
other aligned to aME reference. Such read pairs must also satisfy one of the following three
requirements: (ǉ) they do not have the expected orientation; (Ǌ) they are not aligned to the same
chromosome or (ǋ) the fragment length is not consistent with the fragment length distribution
(p-value ≤ ǈ.ǈǈǍ). For each type of ME (ALU, Lǉ, SVA and HERV-K), Tangram clusters these
candidate read pairs with a customized nearest-neighbor algorithm [ǉǋǋ, ǉǋǌ] according to their
fragment center position (aligned position of the uniquely aligned mate plus one half of the
median of the fragment length distribution). During this process read pairs cluster with other
read pairs within a range determined by the fragment length distribution. ĉis algorithm can
handle candidate read pairs from diﬀerent libraries and samples eﬀectively, which can
signiėcantly improve the sensitivity for multiple low-coverage samples. Also, the complexity of
this algorithm is linear in the number of candidate read pairs, making it suitable for large-scale
sequencing data. Read pairs that span intoMEs from the Ǎ’ end will be clustered separately from
those spanning in from the ǋ’ end. Tangram will identify anMEI event if a pair of clusters in the
MEI neighborhood range span into the insertion from both the Ǎ’ and ǋ’ ends (Figure ǋ.ǌ.ǉA).
ĉe true breakpoint should locate somewhere between the end of the Ǎ’ cluster or the beginning
of the ǋ’ cluster. Tangram reports the estimated breakpoint following a leěmost convention
(smallest genomic coordinate of the two positions).
ǋ.ǌ.ǌ MEI ĸĹŉĹķŉĽŃł ĶĵňĹĸ Ńł ňńŀĽŉ-ŇĹĵĸ ŁĵńńĽłĻ ńŃňĽŉĽŃłň
We used the Scissors soěware [ǉǋǍ], both a stand-alone split-read mapping program, and a
library providing an application programming interface (API) to its functions. Scissors uses a
uniquely aligned mate and the fragment length distribution to identify a candidate genomic
Ǐǐ
region for aligning an unaligned/soě-clipped mate (Figure ǋ.ǌ.ǉB).ĉe alignment is performed
using a sensitive and fast algorithm, single instruction multiple data Smith-Waterman (SIMD
SW) [ǉǋǎ]. Several candidate alignments may be obtained in this step, each of which may have a
diﬀerent segment of the read successfully aligned. ĉe unaligned/soě-clipped read is then aligned
to theMEI reference sequences, using the SIMD SW algorithm (Figure ǋ.ǌ.ǉB).ĉis step may
again yield several candidate alignments. Aěer obtaining the candidate alignments, Scissors
calculates a score for each, based on the number of mapped bases and the number of mismatches.
In our application, we use the best SR alignment i.e. the alignment with the highest score.
ǋ.ǌ.Ǎ CĵłĸĽĸĵŉĹMEI ĹŋĹłŉ ĺĽŀŉĹŇĽłĻ ĵłĸ ńŃňŉ-ńŇŃķĹňňĽłĻ
ĉeMEI candidates are ėrst ėltered using the number of supporting fragments. AnMEI
candidate with at least two RP supporting fragments from both Ǎ’ and ǋ’ or at least two SR
supporting fragments were retained. Candidates that are supported by RP signal alone undergo
additional ėltering. If the candidate MEI falls within a predeėned distance of a locus annotated in
RepeatMasker [ǉǋǏ] downloaded fromUCSCGenome Browser [ǉǋǐ] they are removed from
the candidate list. ĉe distance used is the approximate maximum expected fragment length
(p-value ≈ ǈ.ǈǈǍ) in the clusters of supporting RP fragments. For ALU and HERV-K events, the
candidate call is only ėltered out if the MEI in RepeatMasker is also an ALU or HERV-K event.
Lǉ and SVA elements are ėltered out if they also co-locate with an Lǉ, SVA or ALU event in
RepeatMasker. For MEI events supported by SR signal, no further ėltering steps will be applied.
All remainingMEI candidates will be reported in the ėnal VCF ėle. ĉese ėltering steps can be
performed using the PERL program (tangram_filter.pl) that is included in the toolbox.
ǋ.ǌ.ǎ SĵŁńŀĹ ĻĹłŃŉŏńĹ ķĵŀŀĽłĻ ĵłĸ ĻĹłŃŉŏńĹ ŀĽĿĹŀĽļŃŃĸ ķĵŀķŊŀĵŉĽŃł
Tangram uses a Bayesian framework to predict the genotype of MEI events [ǉǉǐ]. We calculate
the posterior probability of a given sample MEI genotype g (i.e. monomphic: REF/REF;
ǏǑ
heterozygousMEI: REF/MEI: or homozygousMEI: MEI/MEI) as follows:
P(gjD) = P(g)P(Djg)P
g0 P(g0)P(Djg0)
(ǋ.ǉ)
whereD is the observed read evidence at the site; and P(g) is the prior probability of the
genotype. By default, Tangram will set a Ěat prior probability (ƥ=Ƨ) for all three possible
genotypes. ĉe data likelihood, P(Djg), is calculated as a binomial probability with the following
parameters:
P(Djg) = pbin(Nalt;Nalt + Nref; pg) (ǋ.Ǌ)
where pg is the expected ratio of MEI alleles to the total number of fragments (~ǈ for
homozygous reference, ǈ.Ǎ for heterozygousMEI and ~ǉ for homozygousMEI);Nref andNalt are
the numbers of read pair fragments that support reference andMEI (alternate) alleles,
respectively. Reference andMEI alleles are deėned as follows: any uniquely mapped read pairs
spanning the predicted breakpoint with a consistent insert size and orientation will be counted as
a fragment supporting the reference allele. Fragments supporting an alternate allele (insertion)
are those inconsistent with the conditions for a reference allele collected during the detection
step (both RP and SR signal). ĉemeaning of the data likelihood is the binominal probability
thatNref + Nalt will Ěuctuate toNalt, given the expected pg.
ĉe genotype reported by Tangram is that with the highest posterior probability and the
output VCF ėle is populated with the corresponding data likelihoods.
ǋ.ǌ.Ǐ SĽŁŊŀĵŉĽŃł ĸĵŉĵ ĻĹłĹŇĵŉĽŃł
ǉ,ǈǈǈ full-length ALUY elements with a ǉǍ bp poly-A tail and a ǉǍ bp target-site duplication
(TSD) sequence were randomly introduced into chromosome Ǌǈ. No elements were allowed to
insert within a ǉǈǈ bp window of the referenceMEs or other simulated elements. Simulated
Illumina paired-end reads were generated for both heterozygous and homozygous insertions,
ǐǈ
with two diﬀerent read lengths (Ǐǎ bp and ǉǈǎ bp) and three diﬀerent coverages (Ǎ, ǉǈ and
Ǌǈ) using theMASON read simulator [ǎǉ] with the default error model. ĉis led to ǉǊ
diﬀerent diﬀerent sets of simulated data. All of the simulated reads had a Ǎǈǈ bp ± ǉǈǈ bp
(median ± standard deviation) insert size. MOSAIK Ǌ.ǈ [ǍǏ] with default parameters was used to
align these simulated reads against a customized human reference that combined hgǉǑ and ǊǋME
sequences (ǌ ALU, ǉǏ Lǉ, ǉ SVA and ǉ HERV) downloaded from RepBase [ǉǋǑ]. ĉe output
BAM ėles fromMOSAIK were sorted by genomic coordinates using BamTools [ǉǌǈ]. ĉe ėnal
BAM ėles served as the input to Tangram for MEI discovery and genotyping.
ǋ.ǌ.ǐ GĹłŃŉŏńĹ ŁĽŎĽłĻ
For each dataset corresponding to a speciėc read length and coverage, we randomly chose Ǎǈǈ
MEI loci. ǌǈǈ were designated as heterozygous sites, and ǉǈǈ as homozygous sites (the ǌ:ǉ ration
was based on experimentally validated genotypes from our earlier study, Stewart et al.
Ǌǈǉǉ [ǉǉǐ]). ĉe genotype accuracy was then calculated for these loci. ĉe random selection and
genotype accuracy experiment was then repeated ėve times (to give a sample of Ǌ,ǍǈǈMEI loci)
and the overall genotype accuracy was determined by averaging the results of the ėve
experiments.
ǋ.ǌ.Ǒ AŀĽĻłŁĹłŉň ĺŃŇ RĹŉŇŃSĹŅ
RetroSeq calls were based on BWA [Ǎǐ] alignments with default parameters as suggested in the
RetroSeq publication.
ǋ.ǌ.ǉǈ IĸĹłŉĽĺĽķĵŉĽŃł Ńĺ ĹŋĹłŉň ĵķŇŃňňMEI ķĵŀŀňĹŉň
In this experiment, we report a detectedMEI event as a match to the locus in Stewart et al.
Ǌǈǉǉ [ǉǉǐ], if the two events are within Ǎǈǈ bp of each other. ĉis criterion is a result of the large
breakpoint uncertainty in Stewart et al. Ǌǈǉǉ.
ǐǉ
ǋ.ǌ.ǉǉ PCR ŋĵŀĽĸĵŉĽŃł
Two sets of ǐǈ loci each were selected for PCR validations from the whole dataset of candidate
loci containing ALU, Lǉ, SVA, and LTR elements. ĉe ėrst set contained loci from the whole
dataset while the second one included only loci identiėed as novel based on previous
studies [ǉǉǐ, ǉǊǌ–ǉǋǈ] and the dbRIP database [ǉǋǉ]. Due to the nature of paired-end reads and
low coverage data, breakpoint coordinates for MEIs were commonly not available. ĉus, an
insertion range was provided for each locus within which theMEI was predicted. For primer
design, ǎǈǈ bp of Ěanking sequence were added upstream and downstream of the insertion
coordinates. ĉe sequence was extracted from the human reference genome (hgǉǑ) using Galaxy
[ǉǌǉ–ǉǌǋ].
ALU elements were masked using RepeatMasker [ǉǋǏ]. Aěer adding a safety margin of Ǎǈ
nucleotides up- and downstream of the insertion coordinates, primers were selected using
BatchPrimerǋ vǊ.ǈ [ǉǌǌ]. ĉe uniqueness of each primer was determined using BLAT [ǉǈǉ]. An
in silico PCR was performed for each locus when at least one primer had more than one match. If
several matches were identiėed or the in silico PCR provided evidence for more than one PCR
product primers were manually redesigned. In these cases the repeat content of the Ěanking
sequence was determined using RepeatMasker. Moreover, the Ěanking sequence was “BlaĨed”
against the human reference genome (hgǉǑ) to determine if the Ěanking sequence matched to
highly homologous loci. In cases with high sequence homology, the other orthologous sequences
were retrieved using the UCSC genome browser [ǉǋǐ]. Following an alignment of the candidate
locus with the other orthologous loci using BioEdit [ǉǌǍ] primers design was aĨempted in
regions with sequence divergence between the diﬀerent loci. All manually designed primers were
tested with Primerǋ [ǉǌǎ]. For loci with ambiguous PCR results, no ampliėcation, or
ampliėcation of only the empty insertions site, a second primer pair was designed using the same
primer design criteria described above.
Due to the size and high GC-content of SVA elements we used previously designed internal
PCR primers [ǉǉǐ]. ĉe internal primers were designed within the ǋ’ end of the SVA sequence
ǐǊ
matching the consensus sequences of the youngest SVA subfamily (SVA_F) which is
human-speciėc. All PCR primers were ordered from Sigma Aldrich, Inc. (St. Louis, MO).ĉe
PCR primer sequences used in this validation study are available at hĨp://batzerlab.lsu.edu.
ǋ.Ǎ SŃĺŉŌĵŇĹ ĵŋĵĽŀĵĶĽŀĽŉŏ
ĉe source code and instruction are available at hĨps://github.com/jiantao/Tangram. Our
pipeline and tool launcher system, GKNO, available at hĨps://github.com/gkno.
ǐǋ
Reviewing what you have learned and learning anew, you
are ėt to be a teacher.
Confucius
4
Concluding Remarks
SŉŇŊķŉŊŇĵŀ ŋĵŇĽĵŉĽŃłň are now recognized as one of the major contributors to humandiseases and phenotypic variants. In order to enable downstream functional studiesabout these variants, it is ėrst necessary to establish reliable methods to detect them.
Current excitement surrounding the SV discoveries mainly stem from the advent of NGS
sequencing technologies. ĉe focus of my PhD study in theMarth lab is to develop eﬃcient and
lightweight computational methods for SV detection in the human genome based on NGS data.
ǐǌ
ǌ.ǉ SŊŁŁĵŇŏ
ǌ.ǉ.ǉ CNV ĸĹŉĹķŉĽŃł ĺŇŃŁ ĹŎŃł ķĵńŉŊŇĹ ňĹŅŊĹłķĽłĻ ĸĵŉĵ
DNA capture technologies combined with high-throughput sequencing now enable
cost-eﬀective, deep-coverage and targeted sequencing of complete exomes. ĉis is well suited for
SNP discovery and genotyping. However, there has been liĨle aĨention devoted to CNV
detection from exome capture datasets despite the potential impact on the protein function for
CNVs in exonic regions.
To ėll this gap, I developed a computational method based on the RD signal to identify CNVs
in exon capture sequencing data. I ėrst established a mathematical model to calculate the
expected number of reads for each target region (gene), which is one of the most diﬃcult
problems in the CNV detection from capture sequencing data. ĉis model does not only
normalize the read depth signal from sample to sample (sample speciėc median read depth) but
also from gene to gene (gene aﬃnity). With the expected read depth, I can calculate the data
likelihood of each gene-sample site (GSS) and each possible genotype based on the Poisson
(Normal) distribution with a correction factor (ODF) accounting for the random noise and PCR
bias. I plugged these data likelihoods to a Bayesian framework to calculate the posterior
probability for each possible copy number. CNVs can be detected as those GSS whose largest
posterior probability is not from copy number Ǌ.
I evaluated this algorithm on ǉǈǈǈGP exon capture sequencing data generated from four
sequencing centers. Totally my program detected Ǒǎ heterozygous deletions and ǋǑ duplications
from about ǌ.ǎƻ of the human exome (Table Ǌ.Ǌ.ǋ, Ǌ.Ǌ.ǌ, Ǌ.Ǌ.Ǎ and Ǌ.Ǌ.ǎ). Due to the limitation
of the data quality, the estimated detection eﬃciency from both mathematical derivation and
simulation experiments is about Ǎǈƻ. I derived a statistical measurement, quality index (QI), to
describe the relationship between the quality of sequencing data (coverage and ODF) and the
estimated detection eﬃciency. From the calculation, I found the detection eﬃciency of my
program could be signiėcantly improved if beĨer data are available (high coverage and/or low
ǐǍ
ODF) (Figure Ǌ.Ǌ.ǍB). Based on the number of CNV calls in this study and the estimated
sensitivity, I gave the approximate number of genes aﬀected by CNV, ǈ.ǎǊ, in each individual
genome on average. Finally the result of PCR validation experiments performed on Ǌǌ random
selected heterozygous deletion events indicated an FDR of ǉǊ.Ǎƻ, which is comparable to or
lower than the FDR of CNV detectors based on the RD signal in ǉǈǈǈGP Pilot ǉ low coverage
data (Table Ǌ.Ǌ.Ǐ).
ǌ.ǉ.Ǌ TĵłĻŇĵŁ: Ał ĽłķŀŊňĽŋĹ ŉŃŃŀĶŃŎ ĺŃŇMEI ĸĹŉĹķŉĽŃł
Although it is possible today to detect large deletions and duplications with high accuracy,
eﬀective methods still need to be developed for several other structural variation (SV) types.
MEI was still one of the most diﬃcult SV types to detect and genotype, although a fewmethods
have been published to tackle this problem [ǉǈǍ, ǉǉǐ–ǉǊǈ].
To address this diﬃcult SV type, I developed a novel variant calling program, Tangram,
designed to provide a Ěexible and eﬃcient SV detection tool for genomics researchers to identify
and characterize MEI accurately and sensitively in the human genome. ĉis new tool relied
heavily on split-read mappings performed on all problematic mates (i.e. read pairs where one
end-mate is aligned with high mapping quality, but the other mate is either unmapped or mapped
with many unaligned or “clipped-oﬀ” bases). ĉis approach is diﬀerent from other SV detection
methods employing the SRmapping, which only aĨempt SRmappings in regions where the RP
signal indicates the possibility of a candidate event. I found that a signiėcant fraction of SV events
were supported only by SRmapped reads but not RPmappings (Table ǋ.Ǌ.ǉ). I also developed a
genotyping module to assign genotype data likelihoods based on the number of RP and SR
mappings, as well as the mapping quality values associated with sequencing reads.
I evaluated Tangram on simulated data, applied it to ǉǈǈǈGP data, and compared its
performance to competing methods. ĉe analysis of simulated data indicates a high-degree of
sensitivity, speciėcity and genotype accuracy, across a wide range of sequence coverage values,
both for heterozygous and for homozygousMEI events (Table ǋ.Ǌ.ǉ and ǋ.Ǌ.Ǌ). ĉis experiment
ǐǎ
also demonstrates that the global SRmethod makes a key contribution for the sensitive MEI
discovery (e.g. at ƦƤ coverage nearly ǉǍƻ of events are only detected from SRmappings). It is
also able to report SV events with very accurate breakpoint locations (Figure ǋ.Ǌ.ǉ). I ran
Tangram on deep CEU trio data, and compared our detection performance with two competing
methods, RetroSeq and TEA. Tangram had higher sensitivity to both knownMEI events from
the literature and experimentally validated events found in the ǉǈǈǈGP Pilot dataset, especially
for Lǉ elements. ĉe genotyping accuracy of our program as compared to experimentally
determined genotypes was far beĨer than those two competing methods (Table ǋ.Ǌ.ǌ). Finally,
PCR based validation experiments performed by our collaborators in the Batzer laboratory on
ǉǎǈ randomly selected events indicated an FDR of Ǎ.Ǒǋƻ, an accuracy that equals or exceeds the
SNP calling speciėcity from the best variant callers (Table ǋ.Ǌ.ǐ and ǋ.Ǌ.Ǒ).
ǌ.ǉ.ǋ DĽňķŊňňĽŃł
During my PhD study, I developed two variant callers based on two diﬀerent detection strategies,
read-depth and read-pair plus split-read approaches for two diﬀerent types of sequencing data,
exon capture and whole genome sequence. Because each type of sequencing data has its own
unique characteristic, it is necessary to adopt diﬀerent SV detection algorithms. As mentioned in
Chapter ǉ, compared to the RD algorithm, RP and SR are more superior methods in both
breakpoint resolution and sensitivity to smaller events. However, they are not suitable for the SV
detection in exon capture sequencing data since breakpoints of SV events might be outside the
sequencing regions (breakpoints could locate at intronic or intergenic regions). Due to this
special characteristic of capture sequencing data, candidate read pairs for RP (read pairs span
across the breakpoint) and SR (reads pairs are sampled from the breakpoint) will not be obtained
for the analysis. On the other hand, the RDmethod does not have this limitation. No presence of
breakpoints in sequencing data will not keep it from detecting CNVs properly, since it only
measures the change of read depth coverage in a given genomic region. Moreover, since the RD
algorithm is computationally light-weight it is a good ėt for analyzing large-scale data, e.g.
ǐǏ
sequencing data from ǉǈǈǈGP. In the second research work, MEI detection fromWGS data, RP +
SRmethods instead of the RD algorithm were applied because of their high detection eﬃciency
and breakpoint resolution. Also, althoughMEI belongs to CNVs (changes in the net amount of
DNA), the RD approach is basically blind to this type of SV sinceMEs are highly repetitive DNA
elements. To accurately measure the read depth of a given genomic region, only those uniquely
aligned sequencing reads will be taken into consideration for the statistical analysis and those
reads aligned to multiple genomic positions will be excluded. So for theMEI detection, the RD
method can hardly collect any signal. Moreover, due to the repetitiveness of MEs, traditional RP
and SRmethods also have to be customized enough for the special need of the detection: the
postdoctoral research associate in our lab, Wan-Ping Lee, modiėed our sequencing read aligner,
MOSAIK, in order to provide the extra MEI information (an optional BAM ėle tag, called “ZA”)
in the alignment ėle, which makes it possible for Tangram to detect MEIs with the RPmethod; I
implemented a customized split alignment module in Tangram that can align soě-clipped or
unaligned reads to both normal andME references.
One interesting observation in these two research works is that although based on our study
results from the exon capture sequencing data, we estimated that there should be many CNV
events occur in exonic regions for a given individual, noMEI events were found in exonic regions
when we looked at the detection result for Ǌǉǐ ǉǈǈǈGP phase ǉ samples (Table ǋ.Ǌ.ǎ). ĉis
seemingly contradiction actually has several reasonable explanations: (ǉ) MEI events in exonic
regions are so destructive to genes that the individual carried these variations can not survive
under the selection pressure. Even the shortest ME, Alu, has a length of about ǋǈǈ bp. Lǉ, SVA
and HERV are all thousands bp long. Such a long DNA element inserted in the exon region will
deėnitely has a great impact on the transcription process of a gene. Moreover, non-LTRMEs, Alu,
Lǉ and SVA, carry their own insertion recognition motif, 5'-TTAAAA-3'. One insertion of this
kind of MEs will introduce more insertions at the same area, which will create a MEI “hotspot”.
ĉis is further unfavorable under the selection pressure. (Ǌ) As shown in Figure ǋ.Ǌ.Ǌ, Tangram
has relatively low sensitivity to those low allele frequency events due to the absence or sparseness
ǐǐ
of supporting fragments. It is possible that some low allele frequencyMEIs occur in exonic
regions but Tangrammight not be able to detect them due to the detection eﬃciency issue.
Both of my research works were aiming at developing eﬃcient algorithms for those SVs that
were not addressed by any previous studies or very diﬃcult to detect accurately in the past. My
ėrst research work opens a new door for the exploration of exon capture sequencing data as they
are originally generated only for SNP and INDEL detections. In my second research work, I
developed the state-of-the-art MEI detector that is capable of analyzing large-scale NGS data for
the routine use. By properly introducing newmodules and integrating new algorithms in the
future, my current detector could be expanded to a comprehensive detection toolbox for more
other SV types, such as inversions, translocations and de novo insertions (See Future
directions ǌ.Ǌ).
ǌ.Ǌ FŊŉŊŇĹ ĸĽŇĹķŉĽŃłň
ǌ.Ǌ.ǉ CŊŇŇĹłŉ ķļĵŀŀĹłĻĹň
ĉe future of the SV detection largely depends on the development of sequencing technologies
and new computational methods that can take advantage of them. As most simple SVs, like
deletions and duplications, are already well characterized by current available SV detection
programs, the researching focus has moved to those much diﬃcult SVs, e.g. inversions,
translocations and complex events. Although some SV toolboxes, such DELLY [ǎǍ], Pindel [ǎǌ]
and BreakDancer [ǉǈǎ], have already provided the function to detect these types of events, their
performance is less than satisfactory. For example, recent validation results in the ǉǈǈǈGP
indicated a Ǐǈ – ǉǈǈƻ FDR for current methods aĨempting to detect inversion events. Current
challenges of the SV detection come from technology restrictions, algorithm limitations and
biological complexities. From the aspect of technology, the current generation of sequencing
technology can only provide short length reads (ǋǎbp – ǊǍǈbp) due to the restrictions of
chemical agents and image processing. ĉe length of the sequencing read greatly limits the
ǐǑ
possibilities of the exploration of those SV events buried in the complex genomic context, like
inversions which are usually surrounded by repeat sequences [ǉǌǏ, ǉǌǐ]. In terms of current SV
detection algorithms, most of them rely on the alignment of sequencing reads to the human
reference assembly. ĉis single-reference detection model could cause systematic biases. For
example, most false detections of translocation events are caused by the mis-assembly in the
human genome reference. Also sequencing reads from those highly mutated human genomes,
like those from solid tumor tissues, might be diﬃcult to align to the normal reference. As to the
biological complexities of the human genome, many recent studies have found that SV events
tend to aggregate at some certain genomic locations. For example, a paper published in
Ǌǈǉǉ [ǉǉǐ] forMEI studies reported many “hot spots” forMEI events in the human genome. ĉe
early MEI events set stage for later events. Some newly insertedMEs are very close or even inside
previous MEs. Such complex genomic regions create tremendous diﬃculties for current SV
detection methods.
ǌ.Ǌ.Ǌ PŇŃňńĹķŉ Ńĺ łĹŌ ňĹŅŊĹłķĽłĻ ŉĹķļłŃŀŃĻĽĹň
ĉe fast and continuous advance in both sequencing technologies and computational methods
may oﬀer solutions to all the mentioned issues in the near future.
Many sequencing companies have already announced their third-generation products, such as
Ion Torrent from Life Technologies and PacBio from Paciėc Biosciences. Unlike the
second-generation sequencing (NGS) technology that DNAmolecules need to be ampliėed
through PCR step before sequencing, the third-generation sequencing machine applied a brand
new technique— Single-Molecule Real-Time (SMRT) sequencing technology [ǉǌǑ]. ĉrough
this technique, the sequencing machine can directly observe the synthesis process of a single
DNA polymerase, which signiėcantly increases the sequencing speed and addresses many
shortcomings of the second-generation sequencing technology, such as the PCR bias (not all the
genomic regions can be ampliėed at the same rate due to the GC content diﬀerence) and short
read length. ĉe length of output reads from the third-generation sequencing machine could
Ǒǈ
range from ǉ,ǈǈǈbp to ǉǈ,ǈǈǈbp, which is much longer than that from the NGS technology.
Although this new technology is still not mature yet due to the relative high sequencing error
(currently about ǉǍƻ), it is not hard to imagine the bright future and wide use of it for the
high-quality de novo assembly algorithm, direct identiėcation of haplotypes and the SV detection
in complex and repetitive genomic regions.
ǌ.Ǌ.ǋ PŇŃňńĹķŉ Ńĺ łĹŌ ĵŀĻŃŇĽŉļŁň ĺŃŇ SV ĸĹŉĹķŉĽŃł
As new sequencing technologies become available, there is liĨle doubt that new companion
computational methods will also be developed rapidly. ĉemuch longer read length from the
third generation sequencing machine opens many opportunities for multi-reference or even
reference-free SV detection approaches. ĉemulti-reference system is gradually formed these
years as more and more genomic variants are detected and submiĨed to public variant databases
such as dbSNP [ǉǍǈ] and DGV [ǉǌ]. It is highly possible that variants between newly sequenced
genomes and the reference are already existed in these databases. ĉus detection of these existed
variants will become a simple task if a well-designed aligner can map sequencing reads not only to
the normal reference but also to those alternative alleles. Several aĨempts have already been
carried out based onNGS short reads [ǉǍǉ, ǉǍǊ]. As the continuous expansion and improvement
of variant databases, such as the removal of duplicated entries and the reėnement of breakpoint
positions, this approach could be applied routinely in the future for the detection of common SVs
in large-scale sequencing projects. Another direction of the future SV studies is de novo assembly
method. ĉe performance of current de novo assemblers are greatly restricted by the read length
of the NGS technology. According to recent study results, tens of thousands of errors could be
generated with short sequencing reads by the-state-of-art de novo assemblers [ǉǍǋ] for human
genomes. Moreover, the memory and time cost is prohibitively expensive for current de novo
assemblers for routine uses due to the huge number of reads generated by NGSmachines. ĉe
future development of de novo assemblers will greatly beneėt from the longer length and less
number of reads from the third-generation sequencing technology. Also, the memory usage of de
Ǒǉ
novo assemblers could be signiėcantly reduced by using the compressed data structure during the
assembly process [ǉǍǌ]. With high-quality assembly data, almost all SV types should be easily
identiėed and characterized.
ǌ.Ǌ.ǌ PŇŃňńĹķŉ Ńĺ ĺŊłķŉĽŃł ňŉŊĸĽĹň
ĉe ultimate goal of genomics studies is the continuous improvement of the human health. ĉe
last ten years since the completeness of the Human Genome Project has witnessed the huge
advance in understanding genetic variations that distinguish diﬀerent people and are responsible
for speciėc traits and diseases. Based on the results of numerous genomic variants studies,
genome-wide association studies in humans have been carried out to identify the relationship
between inherited mutations and various common human diseases, such as heart
disease [ǉǍǍ, ǉǍǎ], diabetes [ǉǍǏ–ǉǍǑ], Alzheimer’s disease [ǉǎǈ, ǉǎǉ] and Crohn’s
disease [ǉǎǊ–ǉǎǌ]. Although more than ǉǋ,ǈǈǈ GWAS papers have been published in the last Ǎ
years, germline variants discovered in these researches only address a small fraction of the
heritability of traits and diseases [ǉǎǍ] (less than Ǎǈǈ types). Until recently most GWAS studies
only take SNP variants into account as the SNP database and detection methods are preĨy
mature. However, in the past few years it has been clear that SV is also a major contributor to
human genomic variations and can actually aﬀect more genomic regions than SNPs [ǉǌ, Ǐǋ].
Moreover, since there were no cost-eﬀective methods to call all genetic variants in a large number
of human genomes, currently many GWAS studies only focus their aĨentions on common
variants whose allele frequencies are higher than Ǎƻ. ĉe “missing heritability” gap due to these
two limitations mentioned above is the major boĨleneck for GWAS studies [ǉǎǎ]. ĉe further
development and improvement of both sequencing technologies and SV detection algorithms in
the next ten years will enable the systematical discoveries and characterizations of all types of
germline SVs in the human genome and create a complete list of genomic variants that will greatly
facilitate association studies that can translate the genetic information into phenotypic diversity
or pathogenesis. Here the “complete” does not mean we will sequence the DNA sample from
ǑǊ
every individual in the world. Instead, it is more desirable to have a comprehensive SV database
with the accurate information, such as the type, position and length of a given SV event, at a
satisfactory population allele frequency deepness (say <ǈ.Ǎƻ). For example, to catch variants
down to ǈ.Ǎƻ AFS in a population with Ǒǈƻ sensitivity, only Ǌǋǈ individuals need to be sampled
(log(ƥ  Ƥ:ƭ)=log(ƥ  Ƥ:ƤƤƩ)=Ʀ). As the rapid development of technologies and measuring
algorithms, soon this database could be set up for the downstream functional study and serve as
the major resource to ėll the “missing heritability” gap for future GWAS studies.
Besides those population-scale genomics studies, another branch of human genomics,
personal genomics and medical, is also under fast development. ĉe preliminary results from
variant researches in the human genome have already aĨracted the aĨetions of the public. More
and more people are willing to explore their own genomic information to identify variants that
may threat their future health. ĉis useful information could help them to take some preventive
actions or appropriate treatments to avoid their future health risks. Many personal genomics
projects, e.g. Personal Genome Project (PGP) [ǉǎǏ–ǉǎǑ], have already started to collect and
sequencing DNA samples from a broader space than that of normal large-scale genomics projects,
such as ǉǈǈǈGP, in a long-term run. Also many companies have already sensed the commercial
interest of delivering the genomic analysis to individual customers. For example, ǊǋandMe sells
mail order of SNP genotyping kits for people who want to assess their risks of ǉǏǐ diseases and
estimate their ancestry origins. Other ėrms, such as HelloGenome and deCODEme.com, all oﬀer
similar services to the public. As the cost of WGS rapidly and continuously drops,
sequencing-based services, instead of SNP genotyping kits, may become the mainstream.
However, currently SV studies did not play an important role in these analyses. As the reason
mentioned above, compared to the current knowledge of SNPs, our understanding about SVs is
still not comprehensive enough. Methods that can be used to accurately characterize all types of
SVs are still under developing. Until then personal genomic studies could extend to broader areas
that have never been explored before due to the lack of associations between phenotypes and
genotypes and we should be able to understand more clearly of the pathogenesis of most
Ǒǋ
common and rare diseases. ĉe personal genomic information at that time may becomemuch
valuable to us for the purpose of personalized medicine and therapies that could substantially
improve our health quality.
Another possible high-impact direction of SV researches in the future is the identiėcation and
characterization of somatic mutations for diﬀerent types of cancers in diﬀerent tissues (organs).
Unlike germline mutations that are inherited from parents, somatic mutations are accumulated
during the lifetime of an individual. ĉese mutations are tissue speciėc or even single-cell speciėc
(the mutations you got on your skin due to the sun burn could be much diﬀerent from those in
your stomach due to the alcohol damage) and they are driven factors for various types of
cancers [ǉǏǈ]. ĉese somatic mutations inherited by daughter cells in tumors are under
continuous selections, which make the cancer a “microevolutionary process” [ǉǏǉ–ǉǏǌ]. More
and more “passenger” mutations are introduced during this whole evolutionary process as a result
of the increasing instability of the DNA repair machinery. Cancer genomes, especially those in
solid tumors, are extensively rearranged compared to the normal healthy genome [ǉǏǍ–ǉǏǏ].
Although somatic mutations have been recognized as the “top criminal” that is responsible for the
cancer formation for decades, it is still very diﬃcult to detect driver variations (in most cases SVs)
since they are usually buried in a background of germline (could be ėltered out with normal
control genome from the same patient but it still depends on the sensitive SV detection on both
DNA samples) and “passenger” mutations. ĉe signal to noise ratio (SNR) in the cancer genome
is generally very low. With the help of the current high-resolution genomics technology, several
recurrent fusion genes are discovered in solid tumors, such as prostate [ǉǏǐ] and lung
cancers [ǉǏǑ] but we are still far away from accurately and systematically detecting these driver
mutations from various types of cancers. As the read length from the future sequencing
technology becomes longer and longer, one possible breakthrough of somatic mutations
detection could be de novo assembly method. Using the reference-free method to detect the SVs
in the cancer genome could overcome some limitations of resequencing-based detection
methods, such as the mapping accuracy for those highly mutated genomes and the sensitivity to
Ǒǌ
insertion events, and could reconstruct the organization of the cancer genome at the single
nucleotide resolution. Although there are no publications for this type of study some genomics
scientists have already started to explore this promising research direction [ǉǐǈ]. With the rapid
development of technologies and SV detection algorithms and the broad corporation of
international institutions in large cancer genome projects, such asĉe Cancer Genome Atlas
(TCGA) and International Cancer Genome Consortium (ICGC), searching driven somatic
mutations at the genome scale will become practical and very cost-eﬀective, which could
signiėcantly facilitate the downstream pathogenesis and medicine targeting study.
It will be a long journey to decode all the secrets in the human genome and we are just passing
the start line by studying variants and some of their functional impacts. ĉe full picture of the
human genome will becomemore and more clear as we collect more and more variations like
jigsaw puzzles from diﬀerent sources, population-scale, personal-scale and tissue- and
disease-speciėc data. With suﬃcient data preparation, bold hypothesis proposal and prudent
experiment design from the entire biology community, we are gradually approaching the
comprehensive understanding of the relationship between the genetic information and its
complicated functions. Of course, studying the variants on the DNA sequence level is just a
beginning. Many other inheritable factors, such as epigenetic variants, also plays a signiėcant role
in aﬀecting our phenotypic traits [ǉǐǉ–ǉǐǋ] or susceptibility to diﬀerent diseases, including
Angelman syndrome [ǉǐǌ], Prader-Willi syndrome [ǉǐǍ], Beckwith-Wiedemann
syndrome [ǉǐǎ, ǉǐǏ] and various types of cancers [ǉǐǐ–ǉǑǎ]. Some epigenetics problems, e.g.
methylation variation detection, are very similar to those in the SV detection (CNV detection).
Many methods used for SV discovery in high throughput sequencing data could also be
transplanted easily on large-scale epigenetic data [ǉǑǏ–ǉǑǑ]. So the future achievement of SV
studies could also greatly beneėt the development of epigenetics. ĉe progress of variant studies,
including SNP, INDEL, SV and epigenetic variations, will accelerate the process of ėnding
“missing heritability” in the human genome and facilitate downstreamGWAS studies, which
could potentially bring revolutionary improvements to the human health.
ǑǍ
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